KR20230081492A - Aromatherapy composition for psychological stability and cellulite reduction and manufacturingmethod thereof - Google Patents
Aromatherapy composition for psychological stability and cellulite reduction and manufacturingmethod thereof Download PDFInfo
- Publication number
- KR20230081492A KR20230081492A KR1020210169570A KR20210169570A KR20230081492A KR 20230081492 A KR20230081492 A KR 20230081492A KR 1020210169570 A KR1020210169570 A KR 1020210169570A KR 20210169570 A KR20210169570 A KR 20210169570A KR 20230081492 A KR20230081492 A KR 20230081492A
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- weight
- cellulite
- skin
- essential oil
- Prior art date
Links
- 208000035484 Cellulite Diseases 0.000 title claims abstract description 107
- 206010049752 Peau d'orange Diseases 0.000 title claims abstract description 107
- 238000000222 aromatherapy Methods 0.000 title claims abstract description 88
- 230000036232 cellulite Effects 0.000 title claims abstract description 86
- 239000000203 mixture Substances 0.000 title claims abstract description 74
- 230000009467 reduction Effects 0.000 title claims abstract description 45
- 238000004519 manufacturing process Methods 0.000 title description 15
- 239000000341 volatile oil Substances 0.000 claims abstract description 194
- 241000218691 Cupressaceae Species 0.000 claims abstract description 45
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 34
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 33
- 244000270673 Pelargonium graveolens Species 0.000 claims abstract description 32
- 235000017927 Pelargonium graveolens Nutrition 0.000 claims abstract description 31
- 238000011084 recovery Methods 0.000 claims abstract description 31
- 240000004307 Citrus medica Species 0.000 claims abstract description 30
- 241000283074 Equus asinus Species 0.000 claims abstract description 15
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 15
- 230000000694 effects Effects 0.000 claims description 96
- 239000003921 oil Substances 0.000 claims description 72
- 235000019198 oils Nutrition 0.000 claims description 72
- 239000002199 base oil Substances 0.000 claims description 46
- 230000007423 decrease Effects 0.000 claims description 40
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 35
- 238000002156 mixing Methods 0.000 claims description 31
- 239000013538 functional additive Substances 0.000 claims description 30
- 210000005036 nerve Anatomy 0.000 claims description 23
- 230000002889 sympathetic effect Effects 0.000 claims description 23
- 210000005037 parasympathetic nerve Anatomy 0.000 claims description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 18
- 206010039897 Sedation Diseases 0.000 claims description 17
- 230000036280 sedation Effects 0.000 claims description 17
- 240000007154 Coffea arabica Species 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 244000000231 Sesamum indicum Species 0.000 claims description 14
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 14
- 240000001548 Camellia japonica Species 0.000 claims description 13
- 239000000935 antidepressant agent Substances 0.000 claims description 13
- 229940005513 antidepressants Drugs 0.000 claims description 13
- 235000016213 coffee Nutrition 0.000 claims description 13
- 235000013353 coffee beverage Nutrition 0.000 claims description 13
- 244000013123 dwarf bean Species 0.000 claims description 13
- 230000001430 anti-depressive effect Effects 0.000 claims description 12
- 235000018597 common camellia Nutrition 0.000 claims description 12
- 235000020238 sunflower seed Nutrition 0.000 claims description 12
- 235000019165 vitamin E Nutrition 0.000 claims description 11
- 239000011709 vitamin E Substances 0.000 claims description 11
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 229960004135 idebenone Drugs 0.000 claims description 9
- JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 claims description 9
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 9
- 229940032094 squalane Drugs 0.000 claims description 9
- 235000019501 Lemon oil Nutrition 0.000 claims description 8
- 239000010631 citron oil Substances 0.000 claims description 8
- 239000010639 cypress oil Substances 0.000 claims description 8
- 239000010648 geranium oil Substances 0.000 claims description 8
- 239000010649 ginger oil Substances 0.000 claims description 8
- 239000010501 lemon oil Substances 0.000 claims description 8
- 239000010502 orange oil Substances 0.000 claims description 8
- 239000010668 rosemary oil Substances 0.000 claims description 8
- 229940058206 rosemary oil Drugs 0.000 claims description 8
- 240000002045 Guettarda speciosa Species 0.000 claims description 6
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 6
- 235000019477 peppermint oil Nutrition 0.000 claims description 6
- 230000033764 rhythmic process Effects 0.000 claims description 4
- 230000006641 stabilisation Effects 0.000 claims description 3
- 238000011105 stabilization Methods 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 abstract description 29
- 244000178231 Rosmarinus officinalis Species 0.000 abstract description 26
- 235000006886 Zingiber officinale Nutrition 0.000 abstract description 26
- 235000008397 ginger Nutrition 0.000 abstract description 26
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract description 16
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract description 16
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract description 16
- 235000013399 edible fruits Nutrition 0.000 abstract description 15
- 230000003340 mental effect Effects 0.000 abstract description 13
- 244000061520 Angelica archangelica Species 0.000 abstract description 9
- 244000273928 Zingiber officinale Species 0.000 abstract description 8
- 210000004556 brain Anatomy 0.000 abstract description 8
- 244000003138 Pomo dAdamo Species 0.000 abstract 3
- 230000036626 alertness Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 92
- 239000003205 fragrance Substances 0.000 description 62
- 229940060184 oil ingredients Drugs 0.000 description 59
- 230000035876 healing Effects 0.000 description 52
- 230000035882 stress Effects 0.000 description 48
- 238000011156 evaluation Methods 0.000 description 33
- 206010016256 fatigue Diseases 0.000 description 33
- 239000002537 cosmetic Substances 0.000 description 32
- 230000001965 increasing effect Effects 0.000 description 32
- 238000000605 extraction Methods 0.000 description 31
- 244000131522 Citrus pyriformis Species 0.000 description 27
- 230000002040 relaxant effect Effects 0.000 description 22
- 241000234314 Zingiber Species 0.000 description 19
- 238000005259 measurement Methods 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 239000002699 waste material Substances 0.000 description 18
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 18
- 238000004821 distillation Methods 0.000 description 17
- 230000001926 lymphatic effect Effects 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 16
- 239000002304 perfume Substances 0.000 description 16
- 230000001914 calming effect Effects 0.000 description 15
- 210000000577 adipose tissue Anatomy 0.000 description 14
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 14
- 230000037007 arousal Effects 0.000 description 14
- 230000003247 decreasing effect Effects 0.000 description 14
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 13
- 230000002180 anti-stress Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 244000246386 Mentha pulegium Species 0.000 description 12
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 12
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 12
- 235000016257 Mentha pulegium Nutrition 0.000 description 11
- 235000004357 Mentha x piperita Nutrition 0.000 description 11
- 208000008589 Obesity Diseases 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 11
- 235000001050 hortel pimenta Nutrition 0.000 description 11
- 210000004324 lymphatic system Anatomy 0.000 description 11
- 230000003020 moisturizing effect Effects 0.000 description 11
- 235000020824 obesity Nutrition 0.000 description 11
- 230000036407 pain Effects 0.000 description 10
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 10
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 9
- 239000002386 air freshener Substances 0.000 description 9
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 230000004087 circulation Effects 0.000 description 9
- 239000002781 deodorant agent Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 235000013599 spices Nutrition 0.000 description 9
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 8
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 8
- 206010033307 Overweight Diseases 0.000 description 8
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 8
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 8
- 230000003712 anti-aging effect Effects 0.000 description 8
- 229930006722 beta-pinene Natural products 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 8
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 210000004927 skin cell Anatomy 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 7
- 210000003403 autonomic nervous system Anatomy 0.000 description 7
- 230000003796 beauty Effects 0.000 description 7
- 235000020971 citrus fruits Nutrition 0.000 description 7
- -1 etc.) Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 210000002751 lymph Anatomy 0.000 description 7
- 230000037323 metabolic rate Effects 0.000 description 7
- 230000036651 mood Effects 0.000 description 7
- 210000002374 sebum Anatomy 0.000 description 7
- 210000002027 skeletal muscle Anatomy 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 240000001810 Angelica gigas Species 0.000 description 6
- 235000018865 Angelica gigas Nutrition 0.000 description 6
- 241000207199 Citrus Species 0.000 description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 6
- 235000011613 Pinus brutia Nutrition 0.000 description 6
- 241000018646 Pinus brutia Species 0.000 description 6
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 6
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 229930006739 camphene Natural products 0.000 description 6
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 239000000344 soap Substances 0.000 description 6
- 230000000087 stabilizing effect Effects 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 108700012359 toxins Proteins 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 6
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 5
- 206010067484 Adverse reaction Diseases 0.000 description 5
- 241000723436 Chamaecyparis obtusa Species 0.000 description 5
- 241000951471 Citrus junos Species 0.000 description 5
- 206010029216 Nervousness Diseases 0.000 description 5
- 241000220317 Rosa Species 0.000 description 5
- 241001122767 Theaceae Species 0.000 description 5
- 230000006838 adverse reaction Effects 0.000 description 5
- IPZIYGAXCZTOMH-UHFFFAOYSA-N alpha-eudesmol Natural products CC1=CCCC2CCC(CC12)C(C)(C)O IPZIYGAXCZTOMH-UHFFFAOYSA-N 0.000 description 5
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 5
- 230000000840 anti-viral effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000002808 connective tissue Anatomy 0.000 description 5
- 238000007599 discharging Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229930006696 sabinene Natural products 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 238000001256 steam distillation Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- WMOPMQRJLLIEJV-IUODEOHRSA-N (+)-gamma-eudesmol Chemical compound C1[C@H](C(C)(C)O)CC[C@@]2(C)CCCC(C)=C21 WMOPMQRJLLIEJV-IUODEOHRSA-N 0.000 description 4
- LKKDASYGWYYFIK-UHFFFAOYSA-N (-)-cryptomeridiol Natural products C1CCC(C)(O)C2CC(C(C)(O)C)CCC21C LKKDASYGWYYFIK-UHFFFAOYSA-N 0.000 description 4
- WXQGPFZDVCRBME-QEJZJMRPSA-N (-)-thujopsene Chemical compound C([C@@]1(C)CC=C2C)CCC(C)(C)[C@]11[C@H]2C1 WXQGPFZDVCRBME-QEJZJMRPSA-N 0.000 description 4
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 4
- WMOPMQRJLLIEJV-UHFFFAOYSA-N 7-epi-gamma-eudesmanol Natural products C1C(C(C)(C)O)CCC2(C)CCCC(C)=C21 WMOPMQRJLLIEJV-UHFFFAOYSA-N 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 4
- YJHVMPKSUPGGPZ-UHFFFAOYSA-N Dihydro-beta-eudesmol Natural products C1CC(C(C)(C)O)CC2C(C)CCCC21C YJHVMPKSUPGGPZ-UHFFFAOYSA-N 0.000 description 4
- LLKXNMNOHBQSJW-UHFFFAOYSA-N Elemol Natural products CCC(=C)C1CC(C=CC1(C)C)C(C)(C)O LLKXNMNOHBQSJW-UHFFFAOYSA-N 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- 208000019914 Mental Fatigue Diseases 0.000 description 4
- 206010034568 Peripheral coldness Diseases 0.000 description 4
- 210000000579 abdominal fat Anatomy 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 210000001789 adipocyte Anatomy 0.000 description 4
- 230000036506 anxiety Effects 0.000 description 4
- XFSVWZZZIUIYHP-UHFFFAOYSA-N beta-Eudesmol Natural products CC(C)(O)C1CCC2CCCC(=C)C2C1 XFSVWZZZIUIYHP-UHFFFAOYSA-N 0.000 description 4
- BOPIMTNSYWYZOC-VNHYZAJKSA-N beta-eudesmol Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(C)(O)C)CC[C@]21C BOPIMTNSYWYZOC-VNHYZAJKSA-N 0.000 description 4
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 4
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 4
- 229940026455 cedrol Drugs 0.000 description 4
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 4
- GFJIQNADMLPFOW-UHFFFAOYSA-N cis-Elemol Natural products CC(=C)C1CC(C(C)(C)O)CCC1(C)C=C GFJIQNADMLPFOW-UHFFFAOYSA-N 0.000 description 4
- 239000007933 dermal patch Substances 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 4
- 235000020778 linoleic acid Nutrition 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 4
- 230000019612 pigmentation Effects 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000001624 sedative effect Effects 0.000 description 4
- 230000036560 skin regeneration Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- WXQGPFZDVCRBME-UHFFFAOYSA-N thujopsene Natural products CC1=CCC2(C)CCCC(C)(C)C22C1C2 WXQGPFZDVCRBME-UHFFFAOYSA-N 0.000 description 4
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 3
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 3
- 206010025282 Lymphoedema Diseases 0.000 description 3
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 3
- 235000016278 Mentha canadensis Nutrition 0.000 description 3
- 244000245214 Mentha canadensis Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000000049 anti-anxiety effect Effects 0.000 description 3
- 239000002249 anxiolytic agent Substances 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002996 emotional effect Effects 0.000 description 3
- 238000005265 energy consumption Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000013632 homeostatic process Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 230000032630 lymph circulation Effects 0.000 description 3
- 208000002502 lymphedema Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 210000002820 sympathetic nervous system Anatomy 0.000 description 3
- 239000010891 toxic waste Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 239000001841 zingiber officinale Substances 0.000 description 3
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- NFLGAXVYCFJBMK-BDAKNGLRSA-N (-)-menthone Chemical compound CC(C)[C@@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-BDAKNGLRSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 2
- RNDFUOKDULDZPR-RDBSUJKOSA-N 1-epi-bicyclosesquiphellandrene Chemical compound C1CC(=C)C=C2[C@H](C(C)C)CC[C@@H](C)[C@@H]21 RNDFUOKDULDZPR-RDBSUJKOSA-N 0.000 description 2
- MEMBJMDZWKVOTB-UHFFFAOYSA-N 1-ethyl-2,4-dimethylbenzene Chemical group CCC1=CC=C(C)C=C1C MEMBJMDZWKVOTB-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 208000004611 Abdominal Obesity Diseases 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 2
- 235000010591 Appio Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 206010065941 Central obesity Diseases 0.000 description 2
- 235000009088 Citrus pyriformis Nutrition 0.000 description 2
- 235000007460 Coffea arabica Nutrition 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 241000745768 Pluchea carolinensis Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- OJVGWDJIYBTWDS-UHFFFAOYSA-N Sesamolinol Natural products C1=C(O)C(OC)=CC(OC2C3C(C(OC3)C=3C=C4OCOC4=CC=3)CO2)=C1 OJVGWDJIYBTWDS-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000003561 anti-manic effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000002609 anti-worm Effects 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000000467 autonomic pathway Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037237 body shape Effects 0.000 description 2
- 229940115397 bornyl acetate Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000006397 emotional response Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- HYNGAVZPWWXQIU-UHFFFAOYSA-N lavandulyl acetate Chemical compound CC(C)=CCC(C(C)=C)COC(C)=O HYNGAVZPWWXQIU-UHFFFAOYSA-N 0.000 description 2
- 238000007443 liposuction Methods 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000002078 massotherapy Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 208000013465 muscle pain Diseases 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- 235000021062 nutrient metabolism Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000001734 parasympathetic effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 229940068065 phytosterols Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000008786 sensory perception of smell Effects 0.000 description 2
- KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 description 2
- KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 description 2
- 230000037384 skin absorption Effects 0.000 description 2
- 231100000274 skin absorption Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 2
- GJWSUKYXUMVMGX-UHFFFAOYSA-N (+)-(R)-citronellic acid Natural products OC(=O)CC(C)CCC=C(C)C GJWSUKYXUMVMGX-UHFFFAOYSA-N 0.000 description 1
- ITYNGVSTWVVPIC-XHJNMGKDSA-N (+)-Aromadendrene Natural products C=C1[C@H]2[C@H]([C@H](C)CC2)[C@@H]2C(C)(C)[C@@H]2CC1 ITYNGVSTWVVPIC-XHJNMGKDSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- KKOXKGNSUHTUBV-CABCVRRESA-N (+)-zingiberene Chemical compound CC(C)=CCC[C@@H](C)[C@@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-CABCVRRESA-N 0.000 description 1
- LFJQCDVYDGGFCH-JTQLQIEISA-N (+)-β-phellandrene Chemical compound CC(C)[C@@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-JTQLQIEISA-N 0.000 description 1
- FUCYIEXQVQJBKY-ZFWWWQNUSA-N (+)-δ-Cadinene Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CCC(C)=C21 FUCYIEXQVQJBKY-ZFWWWQNUSA-N 0.000 description 1
- LFJQCDVYDGGFCH-SNVBAGLBSA-N (+/-)-beta-Phellandrene Natural products CC(C)[C@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-SNVBAGLBSA-N 0.000 description 1
- KKOXKGNSUHTUBV-GJZGRUSLSA-N (-)-Zingiberene Natural products [C@@H](CC/C=C(\C)/C)(C)[C@H]1C=CC(C)=CC1 KKOXKGNSUHTUBV-GJZGRUSLSA-N 0.000 description 1
- NPNUFJAVOOONJE-GFUGXAQUSA-N (-)-beta-caryophyllene Chemical compound C1CC(/C)=C/CCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-GFUGXAQUSA-N 0.000 description 1
- ITYNGVSTWVVPIC-XVIXHAIJSA-N (1ar,4ar,7r,7ar,7bs)-1,1,7-trimethyl-4-methylidene-2,3,4a,5,6,7,7a,7b-octahydro-1ah-cyclopropa[e]azulene Chemical compound C([C@@H]1[C@H]2C1(C)C)CC(=C)[C@H]1[C@H]2[C@H](C)CC1 ITYNGVSTWVVPIC-XVIXHAIJSA-N 0.000 description 1
- BWRHOYDPVJPXMF-XHNCKOQMSA-N (1s,4s,6r)-4,7,7-trimethylbicyclo[4.1.0]heptane Chemical compound C1[C@@H](C)CC[C@@H]2C(C)(C)[C@H]12 BWRHOYDPVJPXMF-XHNCKOQMSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- IRAQOCYXUMOFCW-ABHRYQDASA-N (3s,3as,7s,8as)-3,6,8,8-tetramethyl-2,3,4,7,8,8a-hexahydro-1h-3a,7-methanoazulene Chemical compound C1[C@]23[C@@H](C)CC[C@H]3C(C)(C)[C@@H]1C(C)=CC2 IRAQOCYXUMOFCW-ABHRYQDASA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- GJWSUKYXUMVMGX-SECBINFHSA-N (R)-citronellic acid Chemical compound OC(=O)C[C@H](C)CCC=C(C)C GJWSUKYXUMVMGX-SECBINFHSA-N 0.000 description 1
- JNAWJUOCXKIHHG-JXMROGBWSA-N (e)-3,7-dimethyloct-2-en-1-ol Chemical compound CC(C)CCC\C(C)=C\CO JNAWJUOCXKIHHG-JXMROGBWSA-N 0.000 description 1
- KVMWYGAYARXPOL-QDEBKDIKSA-N 2-cyclohexylethyl (e)-2-methylbut-2-enoate Chemical compound C\C=C(/C)C(=O)OCCC1=CC=CC=C1 KVMWYGAYARXPOL-QDEBKDIKSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- OGHBUHJLMHQMHS-UHFFFAOYSA-N 3,7-dimethylocta-2,6-dienyl 2-methylbut-2-enoate Chemical compound CC=C(C)C(=O)OCC=C(C)CCC=C(C)C OGHBUHJLMHQMHS-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- ITYNGVSTWVVPIC-XGFWRYKXSA-N Alloaromadendrene Natural products C([C@@H]1[C@H]2C1(C)C)CC(=C)[C@@H]1[C@@H]2[C@H](C)CC1 ITYNGVSTWVVPIC-XGFWRYKXSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- DNJVYWXIDISQRD-UHFFFAOYSA-N Cafestol Natural products C1CC2(CC3(CO)O)CC3CCC2C2(C)C1C(C=CO1)=C1CC2 DNJVYWXIDISQRD-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 235000006467 Camellia japonica Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016352 Feeling of relaxation Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N Neryl acetate Natural products CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 241001310492 Pectis angustifolia Species 0.000 description 1
- 235000011265 Pelargonium tomentosum Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- BYCHQEILESTMQU-UHFFFAOYSA-N Propionsaeure-nerylester Natural products CCC(=O)OCC=C(C)CCC=C(C)C BYCHQEILESTMQU-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- IRDFGGRWKUKANK-GBJTYRQASA-N Sesquisabinene hydrate Natural products O[C@@]1(C)[C@@H]2[C@@]([C@H](CC/C=C(\C)/C)C)(C2)CC1 IRDFGGRWKUKANK-GBJTYRQASA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000013222 Toxemia Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- PEQMAZJTEUEQJP-JLHYYAGUSA-N [(2e)-3,7-dimethylocta-2,6-dienyl] 2-methylbutanoate Chemical compound CCC(C)C(=O)OC\C=C(/C)CCC=C(C)C PEQMAZJTEUEQJP-JLHYYAGUSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004887 air purification Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- QMAYBMKBYCGXDH-UHFFFAOYSA-N alpha-amorphene Natural products C1CC(C)=CC2C(C(C)C)CC=C(C)C21 QMAYBMKBYCGXDH-UHFFFAOYSA-N 0.000 description 1
- 229930016183 alpha-curcumene Natural products 0.000 description 1
- OFTGWWXCYHSXPO-UHFFFAOYSA-N alpha-zingiberene Natural products CC(CCC=C(C)C)C1C=CC(C)C=C1 OFTGWWXCYHSXPO-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003627 anti-cholesterol Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 238000005899 aromatization reaction Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- PHWISBHSBNDZDX-UHFFFAOYSA-N beta-Sesquiphellandrene Natural products CC(C)=CCCC(C)C1CCC(=C)C=C1 PHWISBHSBNDZDX-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- LFJQCDVYDGGFCH-UHFFFAOYSA-N beta-phellandrene Natural products CC(C)C1CCC(=C)C=C1 LFJQCDVYDGGFCH-UHFFFAOYSA-N 0.000 description 1
- PHWISBHSBNDZDX-LSDHHAIUSA-N beta-sesquiphellandrene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CCC(=C)C=C1 PHWISBHSBNDZDX-LSDHHAIUSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- GXMKKDDGINQVBE-LHDHZVESSA-N beyer-15-ene Chemical compound CC([C@H]1CC2)(C)CCC[C@@]1(C)[C@H]1[C@@]2(C=C2)C[C@]2(C)CC1 GXMKKDDGINQVBE-LHDHZVESSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000011871 bio-impedance analysis Methods 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000009045 body homeostasis Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- DNJVYWXIDISQRD-JTSSGKSMSA-N cafestol Chemical compound C([C@H]1C[C@]2(C[C@@]1(CO)O)CC1)C[C@H]2[C@@]2(C)[C@H]1C(C=CO1)=C1CC2 DNJVYWXIDISQRD-JTSSGKSMSA-N 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- DSSYKIVIOFKYAU-UHFFFAOYSA-N camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- VNLZLLDMKRKVEX-UHFFFAOYSA-N cyclohex-3-enone Chemical compound O=C1CCC=CC1 VNLZLLDMKRKVEX-UHFFFAOYSA-N 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 description 1
- YOCDGWMCBBMMGJ-UHFFFAOYSA-N delta-cadinene Natural products C1C=C(C)CC2C(C(C)C)CCC(=C)C21 YOCDGWMCBBMMGJ-UHFFFAOYSA-N 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- GXMKKDDGINQVBE-UHFFFAOYSA-N ent-beyerene Natural products C1CC2C(C)(C)CCCC2(C)C2C1(C=C1)CC1(C)CC2 GXMKKDDGINQVBE-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- RNDFUOKDULDZPR-UHFFFAOYSA-N epibicyclosesquiphellandrene Natural products C1CC(=C)C=C2C(C(C)C)CCC(C)C21 RNDFUOKDULDZPR-UHFFFAOYSA-N 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- YUIDGONLMDUWNF-UHFFFAOYSA-N ethyl 3-chloro-4h-thieno[3,2-b]pyrrole-5-carboxylate Chemical compound S1C=C(Cl)C2=C1C=C(C(=O)OCC)N2 YUIDGONLMDUWNF-UHFFFAOYSA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229940102465 ginger root Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- BWAXOYJGXIEEOE-UHFFFAOYSA-N italicene Chemical compound C1=C(C)CCC23C(C)CCC3C(C)(C)C21 BWAXOYJGXIEEOE-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000000694 mesotherapy Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000010149 post-hoc-test Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000006155 precocious puberty Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 201000000484 premenstrual tension Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000003368 psychostimulant agent Substances 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- IRDFGGRWKUKANK-UHFFFAOYSA-N sesquisabinene hydrate Chemical compound CC1(O)CCC2(C(CCC=C(C)C)C)C1C2 IRDFGGRWKUKANK-UHFFFAOYSA-N 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- USDOQCCMRDNVAH-UHFFFAOYSA-N sigma-cadinene Natural products C1C=C(C)CC2C(C(C)C)CC=C(C)C21 USDOQCCMRDNVAH-UHFFFAOYSA-N 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- FCSRUSQUAVXUKK-VNHYZAJKSA-N α-Eudesmol Chemical compound C1C[C@@H](C(C)(C)O)C[C@H]2C(C)=CCC[C@@]21C FCSRUSQUAVXUKK-VNHYZAJKSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 참당귀, 유자, 박하, 생강, 편백엽, 편백열매, 로즈마리. 로즈제라늄, 스윗오렌지, 레몬으로부터 천연 에센셜 오일을 추출하고, 참당귀, 유자, 박하, 생강, 편백엽, 로즈마리. 스윗오렌지, 레몬의 에센셜 오일이 뇌의 특정부위를 활성화하여 긴장 및 각성상태를 완화시켜 정신적 편안함과 피로회복, 스트레스 완화, 셀룰라이드 저감을 제공하는 참당귀, 유자, 박하, 생강, 편백엽, 로즈마리. 로즈제라늄, 스윗오렌지, 레몬을 포함하는 에센셜 오일을 함유하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물을 제공하는 것이다.The present invention is angelica, citron, mint, ginger, cypress, cypress fruit, rosemary. Natural essential oils are extracted from rose geranium, sweet orange, and lemon, as well as donkey, citron, mint, ginger, cypress, and rosemary. The essential oils of sweet orange and lemon activate specific parts of the brain to relieve tension and alertness, providing mental comfort, fatigue recovery, stress relief, and cellulide reduction. . To provide an aromatherapy composition for psychological stability and cellulite reduction containing essential oils including rose geranium, sweet orange, and lemon.
Description
본 발명은 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물 및 그 제조방법에 관한 것이다.The present invention relates to an aromatherapy composition for psychological stability and cellulite reduction and a manufacturing method thereof.
셀룰라이트(cellulite)란 혈액순환이나 림프순환의 흐름이 원활하지 못해 생기는 현상으로 지방세포 주변에 독성 노폐물이 축적되면 이를 희석하기 위한 자가중독 방지작용으로 지방조직의 내피에서 밀려나와 파괴된 지방세포와 주변의 조직 등이 수분과 결합되면서 캡슐형태의 결절조직으로 점차 굳어져 보기 흉한 돌출이 형성되는데 의학적 전문용어로 연조직염(cellulitis)이라고 한다. 셀룰라이트는 주로 엉덩이, 허벅지, 하복부에 많이 생기며 작은 결절에서 점차 큰 결절로 발달하여 계속 커지는데 피부 표면은 함몰되거나 돌출되어 체형의 변화를 초래하는데 심하면 림프부종이 발생하여 거동이 힘들고 몸이 무겁게 느껴지며 불쾌감 및 감염에 대한 우려 등 여러 가지가 나타난다. 림프부종이 장기간 치료하지 않고 방치하면 시간이 지날수록 면역성 저하로 만성질환이나 다중감염의 원인이 되고 피부건조와 갈라짐, 피부감염의 위험이 커진다. Cellulite is a phenomenon caused by poor flow of blood or lymph circulation. When toxic wastes accumulate around fat cells, it prevents self-poisoning to dilute them. As the surrounding tissue is combined with moisture, it gradually hardens into a capsular nodular tissue, forming an unsightly protrusion, which is called cellulitis in medical jargon. Cellulite mainly occurs in the buttocks, thighs, and lower abdomen. It develops from small nodules to larger nodules and continues to grow. The skin surface is depressed or protruded, causing changes in body shape. It causes discomfort and concerns about infection. If lymphedema is left untreated for a long period of time, it can cause chronic diseases or multiple infections due to reduced immunity over time, and the risk of skin dryness, cracks, and skin infections increases.
셀룰라이트는 비만인 사람과 남성보다 여성에게 더 많이 발생하며 마른 사람, 어린이, 노인 등 나이와 관계없이 생기는데 보이는 것보다 더 깊은 피부 속에 생성된다. 셀룰라이트 증가의 요인은 호르몬 불균형, 혈액순환장애, 노폐물 축적, 불균형적인 식사, 자극적인 식품(커피, 차, 담배, 술) 남용, 운동부족, 스트레스와 정서적 불안, 호흡장애, 변비, 나쁜 자세가 요인이 된다. 최근에는 업무나 컴퓨터, SNS등으로 인해 책상에 오래 앉아 있거나 나쁜 자세로 오랫동안 지속되는 것이 반복되어도 생기는데 주로 직장인이나 젊은 층에서 셀룰라이트가 증가하는 원인이 되고 있다. Cellulite occurs more in women than in obese people and men, and it occurs regardless of age, such as thin people, children, and the elderly, but it is created deeper in the skin than it looks. The causes of cellulite increase are hormonal imbalance, blood circulation disorder, waste accumulation, unbalanced diet, abuse of stimulating foods (coffee, tea, cigarettes, alcohol), lack of exercise, stress and emotional anxiety, breathing disorder, constipation, and bad posture. become a factor Recently, sitting at a desk for a long time due to work, computers, SNS, etc., or prolonged prolonged exposure to bad posture is repeated.
셀룰라이트가 특히 여성에게 많이 생성되는데 남성의 최상위 피하조직이 얇고 십자형으로 교차하는 그물망의 결합조직으로 되어 있는데 반해 여성은 최상위 피부층이 '거대 정상 지방세포방(large standing fat-cell chamber)'의 구조로 되어 있고 피부의 표피(결합조직)와 연결된 조직의 반경 및 아치형 구분벽을 경계로 분리되어 있어 여성의 노화가 진행되면 표피가 점차 얇아지고 헐거워지면서 표피층으로 이동하고 지방세포방 사이의 결합조직은 얇아지고 지나친 확대로 인한 결합조직의 구조 파괴 또는 얇아지는 현상이 셀룰라이트 축적의 주원인이 되고 있다. Cellulite is produced a lot, especially in women. The uppermost subcutaneous tissue in men is made of a thin, cross-shaped network of connective tissue, whereas in women, the uppermost skin layer has a structure of 'large standing fat-cell chamber'. It is composed of skin epidermis (connective tissue) and is separated by the radius and arcuate partition wall of the tissue connected to it. As a woman ages, the epidermis gradually becomes thinner and looser, moving to the epidermal layer, and the connective tissue between the fat cell compartments Structural destruction or thinning of connective tissue due to thinning and excessive enlargement is the main cause of cellulite accumulation.
특히 여성의 셀룰라이트 생성 원인은 여성호르몬인 에스트로겐(Estrogen)이며 연구를 통해 여성호르몬 변동이 급격하게 일어나는 시기에 셀룰라이트가 생성되는 것으로 알려져 있다. 대표적인 시기는 사춘기 초기 12%, 피임약을 처음 복용하기 시작할 때 19%, 임신중 17%, 폐경기 27%로 폐경기때 가장 많이 증가를 한다고 알려져 있다. 그 이유는 에스토로겐이 여성 성적 발달 및 몸매의 아름다움을 주는 미용을 담당하고 주요 기관에서 노폐물을 배출시켜 저장 역할을 하는데 림프계가 이러한 우리 몸의 노폐물을 정상적인 방식으로 처리하지 못하면 신체순환 문제가 발생하여 셀룰라이트가 생성되는 것으로 알려져 있다. 따라서 비만 여성이 운동과 다이어트를 하여 지방을 감소시켜도 살이 빠지지 않고 복부 및 하체 비만이 되는 이유는 체내에 쌓인 셀룰라이트가 원인인데 과도한 비만은 지방세포로 유입된 수분이나 노폐물이 쉽게 배출이 되지 않아 계속 쌓여서 미세혈액순환이나 림프순환장애가 생겨 셀룰라이트 발생 및 누적으로 인한 신체의 비정상 몸매와 비만이 되고 피부는 신축성을 잃어 처지면서 노화가 진행된다. In particular, the cause of cellulite in women is estrogen, a female hormone, and through research, it is known that cellulite is generated at a time when female hormone fluctuations occur rapidly. The representative period is 12% in early puberty, 19% when first taking birth control pills, 17% during pregnancy, and 27% in menopause, which is known to increase the most during menopause. The reason is that estrogen is responsible for female sexual development and beauty that gives the beauty of the body, and plays a role in storing waste products by discharging waste products from major organs. It is known that light is produced. Therefore, even if obese women reduce fat through exercise and diet, the reason why they do not lose weight and become obese in the abdomen and lower body is because of cellulite accumulated in the body. Accumulated microcirculation or lymphatic circulation disorder occurs, resulting in abnormal body shape and obesity due to the occurrence and accumulation of cellulite, and aging progresses as the skin loses its elasticity and sags.
현대인의 셀룰라이트 축적은 과도한 업무와 스트레스, 운동부족 등이 원인이며 특히 우리몸의 자율신경계에서 낮 신경계인 교감신경과 밤 신경계인 부교감신경계가 서로 길항작용을 하여 항상성과 균형을 유지시켜야 건강해지는데 심리적 스트레스 및 긴장 증가, 업무상 과로와 피곤 등이 쌓이면 교감신경의 작용이 크게 증가하여 자율신경은 균형과 항상성을 잃어 림프순환장애가 생겨 셀룰라이트 증가의 원인이 된다. The accumulation of cellulite in modern people is caused by excessive work, stress, and lack of exercise. In particular, in our body's autonomic nervous system, the sympathetic nervous system, which is the daytime nervous system, and the parasympathetic nervous system, which is the night nervous system, antagonize each other to maintain homeostasis and balance to be healthy. When stress and tension increase, work-related overwork and fatigue accumulate, the action of the sympathetic nerve greatly increases, and the autonomic nerve loses balance and homeostasis, resulting in lymphatic circulation disorder, which causes cellulite to increase.
일반인의 비만에서 마사지, 식이·생활습관 변화로도 셀룰라이트가 없어지지 않을 경우 적극적인 치료를 위해 메조테라피나 람스 시술과 같은 지방흡입 수술을 통해 딱딱하게 굳은 섬유 조직 막을 끊어 제거할 수도 있으나 메조테라피는 피부 진피층에 약물을 넣어 지방을 분해하고 혈액순환을 촉진하는 시술이며, 람스는 단단한 셀룰라이트 조직을 분해한 뒤 뽑아내는 시술이다. 셀룰라이트는 섬유 조직이 지방을 에워싸고 있는 형상이라서, 이 섬유 조직을 깨기 위한 물리적인 힘이 가해져야만 없앨 수 있는데 이러한 약물을 통한 기계적 셀룰라이트 제거는 주변 조직손상을 일으키고 림프계 손상으로 이어져 시술후 노폐물이 제거되지 않아 진피와 피하조직 새에 상처가 아물면서 발생한 흉터의 일종인 셀룰라이트가 증가하고 이러한 셀룰라이트 증가를 제거하기 위해 다시 지방 흡입과 열 자극 또는 재수술은 인체 독이 되는 경우가 많으며 재발이 높다. If cellulite does not go away even with massaging or changes in diet and lifestyle in the general population, it is possible to cut and remove the hardened fibrous tissue membrane through liposuction surgery such as mesotherapy or RAMS procedure for active treatment. It is a procedure that puts drugs in the dermal layer to break down fat and promote blood circulation. Since cellulite is a shape in which fibrous tissue surrounds fat, it can be removed only when physical force is applied to break this fibrous tissue. Mechanical cellulite removal through these drugs causes damage to the surrounding tissue and leads to damage to the lymphatic system, resulting in waste products after the procedure. Cellulite, a type of scar caused by healing of wounds in the dermis and subcutaneous tissue, increases because this is not removed, and liposuction, heat stimulation, or reoperation to remove this cellulite increase are often poisonous to the human body, and recurrence is high. .
셀룰라이트 제거는 일반적인 운동이나 식이조절을 통한 체중감량과는 기전이 전혀 다르며 특정 식습관과 마사지를 통해 개선할 수 있다. 셀룰라이트는 지방세포 주변 독성 노폐물을 함유한 결합조직이 굳어져 생긴 것으로 이를 물리적인 방법으로 끊어주고 림프순환을 촉진시켜 독성배출을 통해 저감시키는 방법으로 림프드레나쥐 마사지가 있다. 이 방법은 셀룰라이트 치유와 관련한 아로마 에센셜 오일을 혼합한 마사지오일을 림프드레나쥐 손마사지의 방법으로 피부에 흡수시켜 림프계를 적극적으로 자극하여 셀룰라이트 분해 및 배출을 돕는 안전한 자연치유 요법이다.Cellulite removal has a completely different mechanism from weight loss through general exercise or diet control, and can be improved through specific eating habits and massage. Cellulite is caused by the hardening of connective tissue containing toxic wastes around fat cells, and there is a lymphatic drain massage as a way to physically cut it off and promote lymphatic circulation to reduce it through toxic discharge. This method is a safe natural healing therapy that helps cellulite decomposition and discharge by actively stimulating the lymphatic system by absorbing massage oil mixed with aroma essential oils related to cellulite healing into the skin in the method of lymphatic drainage hand massage.
림프드레나쥐(Lymphdrainage)란 손 마사지요법으로, 인간을 전인적인 관점에서 건강을 증진시키고 예방하며 치료하는 대체요법의 하나이다. 림프드레나쥐는 자율신경계인 부교감신경계를 적절히 자극하여 저항력 증진, 피로회복, 노폐물 배출 및 수면을 취하게 하며 자율신경계에 이완을 주고 피부의 민감한 말초신경진정 및 피부진정 효과가 크다. 일반 마사지와 달리 손 마사지를 이용하여 림프의 노폐물을 효과적으로 배출시키기 때문에 압이 거의 들어가지 않고 모세혈관 확장 피부, 예민 피부 등 마사지가 어려운 문제성 피부와 부종이 있거나 수술 후 순환에 도움을 받고자 하는 사람들에게 좋은 아로마 마사지이다. 림프드레나쥐는 가장 정적인 마사지로서 비가압식이며 반복적인 동작이 수면을 들게 하여 스트레스와 피로를 풀어주고 림프촉진으로 노페물을 쉽게 배출시켜 현대인의 스트레스 완화, 독소배출 및 충분한 휴식과 숙면을 제공할 수 있는 장점이 있다. Lymphdrainage is a hand massage therapy, which is one of the alternative therapies that promote, prevent, and treat human health from a holistic perspective. Lymph Drainage adequately stimulates the parasympathetic nervous system, which is the autonomic nervous system, to increase resistance, recover from fatigue, discharge waste products, and take sleep. Unlike general massage, hand massage is used to effectively discharge waste products from the lymph, so little pressure is applied, and it is suitable for those who have problematic skin and edema that are difficult to massage, such as capillary dilated skin and sensitive skin, or who want help with circulation after surgery. This is a good aromatherapy massage. Lymphatic drainage is the most static massage, non-pressurized, and repetitive motions induce sleep to relieve stress and fatigue, and promote lymphatic drainage to easily discharge waste products to relieve stress, discharge toxins, and provide sufficient rest and sound sleep for modern people. There are advantages to being
림프계 순환 및 배출효과를 가지는 아로마테라피 에센셜 오일은 방부제, 순환촉진제, 이뇨제, 백혈구 증가 기능 및 림프자극제 역할을 하여 림프계 기능장애를 해소하고 림프계 관련 여러 질환을 치료하고 예방하는데 도움을 주는 것으로 알려져 있다. 셀룰라이트는 만성 염증성 질환으로, 치료시 오히려 잘 먹고 잘 쉬어야 개선에 도움을 주는데 몸의 피로나 스트레스가 쌓이면 오히려 셀룰라이트 축적을 촉진시킨다. 이때는 심한 운동을 피하고 충분한 휴식과 스트레스를 해소시키는 방법을 통해 림프 체액의 흐름을 원활하게 하여 노폐물 배출 촉진과 체내의 영양대사 장애를 개선시켜 효과적으로 셀룰라이트를 제거시킬 수 있는 방법이 아로마테라피 에센셜 오일을 이용한 림프드레나쥐 마사지요법이 있다.Aromatherapy essential oils, which have lymphatic circulation and discharge effects, act as preservatives, circulation promoters, diuretics, leukocyte increasing functions, and lymphatic stimulants to relieve lymphatic dysfunction and help treat and prevent various diseases related to the lymphatic system. Cellulite is a chronic inflammatory disease, so eating well and resting should help improve it. At this time, aromatherapy essential oil is a way to effectively remove cellulite by avoiding severe exercise, taking sufficient rest and relieving stress, and facilitating the flow of lymphatic fluids to promote waste excretion and improve nutrient metabolism disorders in the body. There is a lymphatic drain massage therapy used.
본 발명자는 우리 몸을 순환하는 체액 양의 조절과 노폐물 배출에 관여하는 림프계의 순환작용을 돕고 셀룰라이트 분해와 배출에 효과가 있는 아로마테라피 에센셜 오일 및 마사지오일을 개발하여 림프드레나쥐와 접목시켜 피부속 오일흡수를 돕고 물리적 마사지를 통해 림프계를 자극하여 섬유화된 셀룰라이트 분해 및 배출을 촉진시켜 셀룰라이트의 저감과 미용효과를 볼 수 있는 아로마테라피 림프드레나쥐 바디 마사지오일 조성물을 개발하게 되었다.The present inventors developed an aromatherapy essential oil and massage oil that are effective in decomposing and discharging cellulite, helping the circulation of the lymphatic system, which is involved in controlling the amount of body fluids circulating in the body and discharging waste products, and grafting them with lymphatic drains. We developed an aromatherapy lymphatic drainage body massage oil composition that helps to absorb oil from the inside and stimulates the lymphatic system through physical massage to promote the decomposition and discharge of fibrotic cellulite, reducing cellulite and seeing cosmetic effects.
본 발명의 실시예에 따르면, 참당귀 오일, 유자 오일, 박하 오일, 생강 오일, 편백엽 오일, 로즈마리 오일, 로즈제랴늄 오일, 스윗오렌지 오일, 레몬 오일을 포함하는 에센셜 오일을 포함하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물을 제공한다. According to an embodiment of the present invention, psychological stability and psychological stability including essential oils including angelica oil, citron oil, peppermint oil, ginger oil, cypress oil, rosemary oil, rose geranium oil, sweet orange oil, and lemon oil Provided is an aromatherapy composition for reducing cellulite.
상기 에센셜 오일은 참당귀 오일 5 ~ 20 중량%, 유자 오일 5 ~ 20 중량%, 박하 오일 5 ~ 20 중량%, 생강 오일 5 ~ 20 중량%, 편백엽 오일 5 ~ 20 중량%, 로즈마리 오일 5 ~ 20 중량%, 로즈제랴늄 오일 5 ~ 20 중량%, 스윗오렌지 오일 5 ~ 20 중량%, 레몬 오일 5 ~ 20 중량% 포함할 수 있으나, 이에 제한되는 것은 아니다. The essential oils include 5 to 20% by weight of angelica oil, 5 to 20% by weight of citron oil, 5 to 20% by weight of peppermint oil, 5 to 20% by weight of ginger oil, 5 to 20% by weight of cypress oil, and 5 to 20% by weight of rosemary oil. 20% by weight, 5 to 20% by weight of rose geranium oil, 5 to 20% by weight of sweet orange oil, and 5 to 20% by weight of lemon oil, but is not limited thereto.
상기 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 편백종자 오일, 동백종자 오일, 세서미종자 오일, 커피그린빈 오일 및 해바라기씨 오일을 포함하는 베이스 오일 및 Vitamin E, 스쿠알란(Squalane), 이데베논(Idebenone), 유자씨추출액을 포함하는 기능성 첨가제를 더 포함할 수 있으나, 이에 제한되는 것은 아니다. The aromatherapy composition for psychological stability and cellulite reduction is a base oil including cypress seed oil, camellia seed oil, sesame seed oil, coffee green bean oil and sunflower seed oil, and Vitamin E, squalane, and idebenone. , It may further include a functional additive including citron seed extract, but is not limited thereto.
상기 베이스 오일, 에센셜 오일 및 기능성 첨가제를 포함하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 베이스 오일 74 ~ 98 중량%, 에센셜 오일 1 ~ 21 중량% 및 기능성 첨가제 1 ~ 5중량%를 포함할 수 있으나, 이에 제한되는 것은 아니다. The aromatherapy composition for psychological stability and cellulite reduction comprising the base oil, essential oil and functional additives may include 74 to 98% by weight of the base oil, 1 to 21% by weight of the essential oil and 1 to 5% by weight of the functional additives. However, it is not limited thereto.
상기 베이스 오일은 편백종자 오일 5 ~ 40 중량%, 동백종자 오일 5 ~ 40 중량%, 세서미종자 오일 5 ~ 40 중량%, 커피그린빈 오일 5 ~ 40 중량% 및 해바라기씨 오일 5 ~ 40 중량% 포함할 수 있으나, 이에 제한되는 것은 아니다. The base oil may include 5 to 40% by weight of cypress seed oil, 5 to 40% by weight of camellia seed oil, 5 to 40% by weight of sesame seed oil, 5 to 40% by weight of coffee green bean oil, and 5 to 40% by weight of sunflower seed oil. It may be, but is not limited thereto.
상기 기능성 첨가제는 Vitamin E 5 ~ 40 중량%, 스쿠알란(Squalane) 5 ~ 40 중량%, 이데베논(Idebenone) 2 ~ 20 중량%, 유자씨추출액 5 ~ 40 중량% 포함할 수 있으나, 이에 제한되는 것은 아니다. The functional additive may include 5 to 40% by weight of Vitamin E, 5 to 40% by weight of Squalane, 2 to 20% by weight of Idebenone, and 5 to 40% by weight of citron seed extract, but is not limited thereto. no.
상기 에센셜 오일은 RSMR(Relative Sensorimotor Rhythm) 증가, RG(Relative gamma power) 감소, 교감신경(NormLF) 감소, 부교감신경(NormHF) 증가, 진정, 이완, 마음안정, 항우울, 피로회복 및 스트레스 완화 효과를 나타낼 수 있으나, 이에 제한되는 것은 아니다. The essential oil increases RSMR (Relative Sensorimotor Rhythm), RG (Relative gamma power) decreases, sympathetic nerve (NormLF) decreases, parasympathetic nerve (NormHF) increases, sedation, relaxation, mind stability, antidepressant, fatigue recovery and stress relief effects It may represent, but is not limited thereto.
본 발명의 다른 실시예에 따르면, 편백종자 오일, 동백종자 오일, 세서미종자 오일, 커피그린빈 오일 및 해바라기씨 오일을 혼합하여 베이스 오일을 제조하는 단계; 참당귀 오일, 유자 오일, 박하 오일, 생강 오일, 편백엽 오일, 로즈마리 오일, 로즈제랴늄 오일, 스윗오렌지 오일, 레몬 오일을 혼합하여 에센셜 오일을 제조하는 단계; Vitamin E, 스쿠알란(Squalane), 이데베논(Idebenone), 유자씨추출액을 포함하는 기능성 첨가제를 제조하는 단계;및 상기 베이스 오일, 에센셜 오일 및 기능성 첨가제를 혼합하는 단계를 포함하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물 제조방법을 제공한다. According to another embodiment of the present invention, preparing a base oil by mixing cypress seed oil, camellia seed oil, sesame seed oil, coffee green bean oil and sunflower seed oil; Preparing an essential oil by mixing angelica oil, citron oil, mint oil, ginger oil, cypress oil, rosemary oil, rose geranium oil, sweet orange oil, and lemon oil; Preparing functional additives including Vitamin E, Squalane, Idebenone, and citron seed extract; and psychological stability and cellulite reduction including mixing the base oil, essential oil and functional additives. It provides a method for preparing an aromatherapy composition for use.
상기 베이스 오일, 에센셜 오일 및 기능성 첨가제를 혼합하는 단계는 베이스 오일 74 ~ 98 중량%, 에센셜 오일 1 ~ 21 중량% 및 기능성 첨가물 1 ~ 5중량%를 혼합할 수 있으나, 이에 제한되는 것은 아니다. In the mixing of the base oil, essential oil and functional additives, 74 to 98% by weight of the base oil, 1 to 21% by weight of the essential oil, and 1 to 5% by weight of the functional additive may be mixed, but is not limited thereto.
상기 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물 제조방법에서 베이스 오일, 에센셜 오일 및 기능성 첨가제의 혼합 구성요소 및 혼합 비율은 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물과 동일하다. In the method for preparing the aromatherapy composition for psychological stability and cellulite reduction, the mixing components and mixing ratios of the base oil, essential oil and functional additives are the same as those of the aromatherapy composition for psychological stability and cellulite reduction.
본 발명의 또 다른 실시예에 따르며나 상기 조성물을 포함하는 마사지 오일, 향수, 비누, 입욕제, 화장품 또는 향장품을 제공한다. According to another embodiment of the present invention, massage oil, perfume, soap, bath additives, cosmetics or cosmetics containing the composition are provided.
본 발명의 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 오일타입일 수 있으나 이에 제한되는 것은 아니다.The aromatherapy composition for psychological stability and cellulite reduction of the present invention may be an oil type, but is not limited thereto.
본 발명의 아로마 에센셜 오일과 베이스 오일을 포함하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 100% 천연 아로마테라피 에센셜 오일이며 입자가 매우 미세하여 지방이 풍부한 조직에 빠르게 도달하여 특정영역을 자극해 치유효과가 신속히 나타나며, 인체에 흡수된 에센셜 오일 성분은 몸에 축적되지 않고 전량 체외로 배출되어 부작용 없이 장기간 사용할 수 있으며 몸과 마음의 균형과 활력을 주는 향기치유 효과를 가지는 장점이 있다. The aromatherapy composition for psychological stability and cellulite reduction containing aroma essential oil and base oil of the present invention is 100% natural aromatherapy essential oil, and its particles are very fine, so it quickly reaches fat-rich tissues and stimulates and heals specific areas. The effect appears quickly, and the essential oil components absorbed into the body are not accumulated in the body but are discharged out of the body in full, so it can be used for a long time without side effects, and has the advantage of having a scent healing effect that balances and vitalizes the body and mind.
본 발명의 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 감정적 스트레스완화, 근육 긴장과 피로감 해소, 국부적, 전체적 림프순환 활성, 국부적 혈액순환을 증진 또는 완화시켜 몸과 마음을 치유하고 예방하는 자연요법의 특성을 가진다. The aromatherapy composition for psychological stability and cellulite reduction of the present invention is a natural therapy for healing and preventing the body and mind by relieving emotional stress, relieving muscle tension and fatigue, promoting or relieving local and global lymphatic circulation, and local blood circulation. have a characteristic
본 발명의 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 진정, 이완, 마음안정, 항우울, 피로회복 및 스트레스 완화 효과를 가지면서 림프순환을 도와 노폐물과 독소를 배출시켜 효과적인 셀룰라이트 저감에 도움이 되는 유효성분을 함유한 100% 천연 아로마테라피 에센셜 오일 조성물과 에센셜 오일의 유용성분의 휘발을 막고 에센셜 오일의 고농도를 희석하여 피부미용과 마사지를 돕는 베이스 오일 조성물, 베이스 오일 및 아로마테라피 에센셜 오일 조성물의 산화 및 산패방지로 오일 장기저장, 피부흡수촉진, 항노화, 피부재생, 노폐물과 독소를 배출하는 효과를 가지는 기능성 첨가물을 포함하여 피부미용, 셀룰라이트 저감 및 심신 치유효과를 기대할 수 있다.The aromatherapy composition for psychological stabilization and cellulite reduction of the present invention has soothing, relaxation, mind stabilizing, antidepressant, fatigue recovery and stress relieving effects, while helping lymph circulation to discharge wastes and toxins, thereby helping to effectively reduce cellulite. A 100% natural aromatherapy essential oil composition containing active ingredients that are essential oils, a base oil composition that prevents volatilization of useful components of essential oil and dilutes the high concentration of essential oil to help skin care and massage, and a base oil and aromatherapy essential oil composition By preventing oxidation and rancidity, long-term storage of oil, promotion of skin absorption, anti-aging, skin regeneration, and functional additives that have the effect of discharging waste materials and toxins can be expected for skin care, cellulite reduction, and healing effects of mind and body.
본 발명의 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 피부 또는 전신 아로마테라피 마사지오일 또는 기능성 화장품 제형의 주원료 또는 부원료로 사용할 수 있으며, 에센셜 오일은 향수 또는 방향제의 부형제로, 비누 또는 입욕제와 같은 생활용품의 첨가제 또는 분말, 과립, 스프레이 또는 액상 등의 다양한 용도로 향장품에 적용할 수 있는 장점을 가지고 있어 상업적 활용성이 높은 장점이 있다.The aromatherapy composition for psychological stabilization and cellulite reduction of the present invention can be used as a main or auxiliary material for skin or body aromatherapy massage oil or functional cosmetic formulations, and essential oils are used as excipients for perfumes or fragrances, such as soaps or bath products. It has the advantage of being applicable to cosmetics for various purposes such as additives or powders, granules, sprays or liquids of products, and thus has high commercial applicability.
또한 본 발명의 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 향강도가 2,000 A.I.(Arbitrary unit) 이상으로 향기가 매우 강하여 다양한 향기산업에 사용될 수 있는데, 예를 들어 화장용품(향수 등), 비누세정용품(목욕비누 등), 실내청소용품(실내, 화장실 크리너 등), 방향용품(자동차용 방향제 등), 목욕용품(허브타입 입욕제 등), 향기상품(문구류, 향기 페이펴 등), 환경용품(오피스용 방향제 등), 공업용품 등의 제조에 사용될 수 있다.In addition, the aromatherapy composition for psychological stability and cellulite reduction of the present invention has a very strong fragrance of 2,000 A.I. (Arbitrary unit) or more and can be used in various fragrance industries. Amenities (bath soap, etc.), indoor cleaning products (indoor, bathroom cleaner, etc.), fragrance products (car air freshener, etc.), bath products (herb-type bath salt, etc.), fragrance products (stationery, fragrance paper, etc.), environmental products ( It can be used in the manufacture of office air fresheners, etc.), industrial supplies, etc.
도 1은 선발된 에센셜 오일 및 셀룰라이트 저감 아로마테라피 화장료 조성물의 제형별 피부이상 반응 검사를 위한 피부 1차 자극시험 과정을 나타낸 것이다.
도 2는 선발된 에센셜 오일 및 셀룰라이트 저감 아로마테라피 화장료 조성물의 제형별 피부첩포검사(Skin Patch Test)에 의한 2차 알레르기 피부반응 검사 과정을 나타낸 것이다.
도 3은 심신치유 및 셀룰라이트 저감 아로마테라피 화장료 조성물의 피부 전신 마사지 전ㆍ후 피부 미용효과를 나타낸 것이다.Figure 1 shows the primary skin irritation test process for the skin adverse reaction test for each formulation of the selected essential oil and cellulite-reducing aromatherapy cosmetic composition.
Figure 2 shows the secondary allergic skin reaction test process by the skin patch test (Skin Patch Test) for each formulation of the selected essential oil and cellulite-reducing aromatherapy cosmetic composition.
Figure 3 shows the skin beauty effect before and after the whole body massage of the body-healing and cellulite-reducing aromatherapy cosmetic composition.
본 명세서에서 어떤 부재가 다른 부재 "상에" 위치하고 있다고 할 때, 이는 어떤 부재가 다른 부재에 접해 있는 경우뿐 아니라 두 부재 사이에 또 다른 부재가 존재하는 경우도 포함한다.In this specification, when a member is said to be located “on” another member, this includes not only the case where a member is in contact with another member, but also the case where another member exists between the two members.
본 명세서에서 어떤 부분이 어떤 구성요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다.In this specification, when a part is said to "include" a certain component, it means that it may further include other components without excluding other components unless otherwise stated.
본 발명의 일 실시예에서 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물을 제공하며, 상기 조성물은 에센셜 오일을 포함하고, 상기 에센셜 오일은 참당귀 오일, 유자 오일, 박하 오일, 생강 오일, 편백엽 오일, 로즈마리 오일, 로즈제랴늄 오일, 스윗오렌지 오일, 레몬 오일을 포함할 수 있다. In one embodiment of the present invention, an aromatherapy composition for psychological stability and cellulite reduction is provided, wherein the composition includes essential oils, wherein the essential oils include donkey oil, citron oil, peppermint oil, ginger oil, and cypress oil. , rosemary oil, rose geranium oil, sweet orange oil, and lemon oil.
상기 에센셜 오일은 증류수를 용매로 하여 증류추출한 물수증기증류법(Water-Steam distillation methods)을 사용하여 추출될 수 있다. The essential oil may be extracted using water-steam distillation methods in which distilled water is used as a solvent and extracted by distillation.
본 발명자의 실험에 의하면, 상기 에센셜 오일은 RSMR(Relative Sensorimotor Rhythm) 증가, RG(Relative gamma power) 감소, 교감신경(NormLF) 감소, 부교감신경(NormHF) 증가, 진정, 이완, 마음안정, 항우울, 피로회복 및 스트레스 완화 효과를 나타낸다. According to the experiment of the present inventors, the essential oil increases RSMR (Relative Sensorimotor Rhythm), RG (Relative gamma power) decreases, sympathetic nerve (NormLF) decrease, parasympathetic nerve (NormHF) increase, sedation, relaxation, mind stability, antidepressant , shows fatigue recovery and stress relieving effects.
따라서 상기 에센셜 오일을 포함하는 아로마테라피 조성물은 뇌의 긴장 및 각성상태를 완화시켜 정신적 편안함을 제공하기에 향장산업(아로마테라피, 아로마콜로지) 분야에 광범위하게 적용될 수 있으며, 림프드레나쥐 요법이나 일반 마사지에 적용하여 체내에 축적된 지방성 셀룰라이트의 적극적인 분해와 림프계 자극과 순환을 통해 셀룰라이트 및 노폐물 제거를 돕고 피부미용 증진과 건강한 몸매로 가꾸어 주면서 심신의 활력증진 및 스트레스 완화 효과를 제공한다. Therefore, the aromatherapy composition containing the essential oil can be widely applied in the cosmetic industry (aromatherapy, aromacology) to provide mental comfort by alleviating the tension and wakefulness of the brain, lymphatic drainage therapy or general When applied to massage, it actively decomposes fatty cellulite accumulated in the body, stimulates and circulates the lymphatic system, helps to remove cellulite and waste products, promotes skin beauty and keeps a healthy body, and provides the effect of enhancing physical and mental vitality and relieving stress.
상기 에센셜 오일의 분자량은 매우 작고 휘발성이 강해 후각 및 피부를 통해 아로마 오일의 화학성분이 체내 깊숙이 빠르게 침투하여 신진대사동안 노페물 제거, 혈액순환 개선 및 신경조직 안정화로 긴장과 불안, 초초, 스트레스 및 피로 등이 빠르게 해소되고 그 효과가 크게 나타날 수 있다. The molecular weight of the essential oil is very small and volatile, so the chemical components of the aroma oil quickly penetrate deep into the body through the sense of smell and skin, removing waste products during metabolism, improving blood circulation, and stabilizing nervous tissue, resulting in tension and anxiety, irritation, stress and fatigue The back is quickly resolved and the effect can be significant.
상기 에센셜 오일의 성분은 인체에 흡수되어도 몸에 축적되지 않고 인체 침투 후 3~4시간, 비만한 사람 또는 환자의 경우 14시간 정도면 거의 전량이 체외로 배출되어 안전하며 장기적으로 사용을 해도 부작용 없이 심신의 활력 또는 평온을 주어 자율신경의 밸런스를 유지시켜 면연력 증가 및 자연치유력을 높이는 효능을 가진다. Even if the components of the essential oil are absorbed into the body, they do not accumulate in the body, and almost all of them are discharged out of the body in 3 to 4 hours after penetration into the body, or 14 hours in the case of obese people or patients. It has the effect of increasing immunity and natural healing power by maintaining the balance of the autonomic nerve by giving vitality or tranquility to the mind and body.
본 발명의 용어 "에센셜 오일"은 1개의 단일 식물형 및 식물종이 만들어낸 향이 나는 식물 재료를 물리적인 방법으로 얻어낸 휘발성 물질을 말한다. 즉 향기나는 식물의 잎, 줄기, 꽃, 껍질, 뿌리나 다른 식물 요소에서 물 또는 수증기 증류법으로 천연 그대로의 원료에서 또는 기계적인 압착법으로 감귤류의 외과피에서 얻어지는 산물로 물리적인 방법으로 수용성으로부터 분리된 휘발성 향기물질의 통칭이다.As used herein, the term "essential oil" refers to a volatile substance obtained by a physical method from a plant material having a scent produced by one single plant type and plant species. In other words, it is a product obtained from the peel of citrus fruits by mechanical compression or from natural raw materials by water or steam distillation from the leaves, stems, flowers, peels, roots or other plant elements of aromatic plants, separated from water-soluble by physical methods. It is a common name for volatile fragrance substances.
본 발명의 "참당귀(Angelica gigas, Korean angelica)"는 미나리과에 속하는 다년생 초본류로 우리나라와 중국의 동북부 지역에서 자생 분포하며 천연 에센셜 오일의 추출은 건조한 뿌리를 증류추출하여 얻어지며 에센셜 오일의 주요 성분은 아래표와 같다. 참당귀 에센셜 오일은 신체와 여성의 자궁을 따뜻하게 하는 효과가 있으며 관상동맥의 혈류량을 촉진시키고, 적혈구 생성을 도와 주로 여성의 약으로 많이 활용된다. 해독과 이뇨작용이 우수해 림프에 쌓여있는 노폐물 배출과 습기제거, 독성제거, 류마티스, 관절염, 체액정체 및 어혈, 셀룰라이트 완화 및 개선시키는 효과가 알려져 있다. 아로마 효과로는 향기특성이 날카롭고 찌르는 듯한 그린 계열 셀러리향과 따뜻한 매운 페퍼향이 머리를 맑게 해주고 마음의 활력증진과 정신강화 효과를 주며 심신과 피부에 활력을 주는 효과가 있다." Angelica gigas (Korean angelica)" of the present invention is a perennial herb belonging to the Apiaceae family and is distributed wildly in Korea and Northeast China. is shown in the table below. Angelica essential oil has the effect of warming the body and the woman's uterus, promotes blood flow in the coronary artery, and helps the production of red blood cells, so it is mainly used as a medicine for women. It has excellent detoxification and diuretic effects, and is known to be effective in discharging wastes accumulated in the lymph, removing moisture, removing toxins, relieving and improving rheumatism, arthritis, body fluid retention and blood clots, and cellulite. As for the aroma effect, the sharp and stinging green celery scent and the warm spicy pepper scent clear the head, enhance the vitality of the mind and strengthen the mind, and give vitality to the mind, body and skin.
alpha-Pinene (3.4)
Camphene (2.0)
dextro-Limonene (2.4)
alpha-elemol (2.7)
gamma-eudesmol (6.6)
1H-Indene, 1-ethylideneoctahydro-7a-methyl-, (1Z,3a.alpha.,7a.beta.)- (2.1)
alpha-eudesmol (3.6)
1H-Indene, 1-ethylideneoctahydro-7a-methyl-, (1E,3a.alpha.,7a.beta.)- (3.0)
Decursin (0.2)Nonane (2.1)
alpha-Pinene (3.4)
Camphene (2.0)
dextro-Limonene (2.4)
alpha-elemol (2.7)
gamma-eudesmol (6.6)
1H-Indene, 1-ethylideneoctahydro-7a-methyl-, (1Z,3a.alpha.,7a.beta.)- (2.1)
alpha-eudesmol (3.6)
1H-Indene, 1-ethylideneoctahydro-7a-methyl-, (1E,3a.alpha.,7a.beta.)- (3.0)
Decursin (0.2)
2. Notes : Top note
3. 향기특성 : 날카롭고 찌르는 듯한 그린계열 셀러리향, 페퍼향, 따뜻한 매운향
4. 향기치유 : 정신강화, 활력증진, 심신안정
5. 치유효과 : 항산화, 항염증, 항균, 면역성강화, 혈액순환촉진, 월경조절, 통증경감, 보혈작용, 뇌기능 및 간기능 강화, 신경안정, 심신안정, 부인과질환, 빈혈치료, 관절염 치료
6. 용도 : 아로마테라피, 의약용, 향료, 향수, 향신료, 화장수, 세정제, 오데코롱, 비누, 방향제1. Appearance: Transparent yellow liquid
2. Notes: Top note
3. Fragrance Characteristics: Sharp and pungent green celery scent, pepper scent, warm spicy scent
4. Fragrance Healing: Mental strengthening, vitality enhancement, mental and physical stability
5. Healing effect: antioxidant, anti-inflammatory, antibacterial, strengthening immunity, promoting blood circulation, regulating menstruation, reducing pain, blood supply, strengthening brain and liver functions, stabilizing nerves, stabilizing mind and body, treating gynecological diseases, anemia, and arthritis
6. Usage: Aromatherapy, medicine, fragrance, perfume, spice, lotion, detergent, eau de cologne, soap, fragrance
본 발명의 "유자(Citrus junos Siebold ex Tanaka)"는 중국원산인 운향과의 과일 나무(상록 활엽 관목)로 국내는 주재배지인 전남을 비롯한 남부지역에서 재배되고 있다. 가을에 수확되는 유자는 다른 과일에 비해 비타민C, 구연산, 엽산 등과 같이 저항력과 면역력을 기르는데 유익한 성분을 많이 함유하고 있으며 배농 및 배설작용을 해서 몸 안에 쌓인 노폐물을 밖으로 내보낸다. 특히 유자과피로부터 냉압착추출로 얻어진 유자 에센셜 오일에는 모세혈관을 강화시키는 헤스페리딘 성분이 다량 함유하고 있어 뇌혈관 장애와 풍을 막아주고 준다. 유자 에센셜 오일의 주요 성분은 아래표와 같으며 오렌지와 유사한 림프 흐름을 자극하여 림프부종 치료, 노폐물 제거, 셀룰라이트 분해에 효과가 있다." Citrus junos Siebold ex Tanaka " of the present invention is a fruit tree (evergreen broad-leaved shrub) of the Rutaceae family native to China and is cultivated in the southern region including Jeonnam, the main cultivation area in Korea. Compared to other fruits, yuzu harvested in the fall contains a lot of beneficial ingredients for developing resistance and immunity, such as vitamin C, citric acid, and folic acid. In particular, citron essential oil obtained by cold-pressing extraction from citron peel contains a large amount of hesperidin, which strengthens capillaries, preventing cerebrovascular disorders and wind. The main components of citron essential oil are shown in the table below. It stimulates lymph flow similar to orange, and is effective in treating lymphedema, removing waste products, and dissolving cellulite.
beta-Pinene (7.3)
Sabinene (6.4)
D-Limonene (9.0)
Limonene (15.2)
gamma-terpinene (5.4)
Terpinolene (2.0)
Linalool (2.9)
Pentadecanoic acid (2.7)
Linoleic acid (2.7)alpha-Pinene (8.6)
beta-Pinene (7.3)
Sabinene (6.4)
D-Limonene (9.0)
Limonene (15.2)
gamma-terpinene (5.4)
Terpinolene (2.0)
Linalool (2.9)
Pentadecanoic acid (2.7)
Linoleic acid (2.7)
2. notes : Medium
3. 향기특성 : 톡 쏘는듯한 따뜻하고 달콤한 시트러스 부케향이 생기와 기분을 돋우는 향,
4. 치유효과 : 정신고양, 정신피로회복, 항스트레스(긴장, 신경쇠약), 피부(수렴, 해독), 집중력향상, 면역체계강화, 천식치료, 해열, 통증완화, 항균, 항바이러스, 피지분비조절
5. 용도 : 아로마테라피, 피부미용, 향수, 화장품, 스킨케어용, 과일차, 요리, 향수, 시프레.1. Appearance: Pale yellow transparent liquid
2. notes: Medium
3. Fragrance Characteristics: A pungent, warm and sweet citrus bouquet fragrance that excites and uplifts the mood,
4. Healing effect: Mental enhancement, mental fatigue recovery, anti-stress (tension, nervous breakdown), skin (convergence, detoxification), concentration improvement, immune system strengthening, asthma treatment, fever relief, pain relief, antibacterial, antiviral, sebum secretion control
5. Usage: Aromatherapy, skin care, perfume, cosmetics, skin care, fruit tea, cooking, perfume, chypre.
본 발명의 "박하(Mentha canadensis L.)"는 꿀풀과의 다년생 초본류인 향신료로 국내 자생종으로 전초를 수증기증류법에 의해 에센셜 오일을 얻으며 연한 올리브색의 용액으로 언더톤으로 짙은 발삼향이 나며 건조후에는 달콤하고 깨끗한 향기를 띠는 신선하고 강한 풀향과 민트향이 난다. 박하 에센셜 오일의 주요 성분은 아래 표와 같으며 진통, 마취, 근육통, 소염, 장내 가스제거, 구취, 구풍, 항염증 등 페퍼민트와 거의 유사한 효과를 가지고 있다. 박하 에센셜 오일은 특히 혈액 및 림프에 특별한 친화성이 있어 모든 조직에 신선한 활력을 주어 새로운 혈소판을 생성하는 비장의 재생 활력을 자극하여 림프액과 조직액 순환을 가속화시켜 림프계의 기능을 활성화시키는 효과가 알려져 있다. "Peppermint ( Mentha canadensis L. )" of the present invention is a spice that is a perennial herb of the family Lamiaceae. It is a domestic species native to Korea. Essential oil is obtained by steam distillation of an outpost. It has a fresh, strong grassy and minty scent that is clean and fresh. The main components of peppermint essential oil are shown in the table below, and it has effects almost similar to those of peppermint, such as pain relief, anesthesia, muscle pain, anti-inflammation, intestinal gas removal, bad breath, mouth breath, and anti-inflammatory. Peppermint essential oil has a special affinity for blood and lymph, so it gives fresh vitality to all tissues, stimulates the regenerative vitality of the spleen to produce new platelets, accelerates the circulation of lymph and tissue fluid, and is known to activate the function of the lymphatic system. .
beta-Pinene (5.4)
D-limonene (4.4)
(±)-Isomenthone (11.0)
(-)-Menthone (8.3)
(±)-p-Menthan-3-ol (3.0)
(±)-menthol (5.5)
Laevo-menthol (2.2)
(R)-(+)-pulegone (3.6)
3-Cyclohexen-1-one, 2-isopropyl-5-methyl- (7.6)
(1R,3S,6S)-3,7,7-Trimethylbicyclo[4.1.0]heptane (6.7)alpha-Pinene (2.6)
beta-Pinene (5.4)
D-limonene (4.4)
(±)-Isomethone (11.0)
(-)-Menthone (8.3)
(±)-p-Menthan-3-ol (3.0)
(±)-menthol (5.5)
Laevo-menthol (2.2)
(R)-(+)-pulegone (3.6)
3-Cyclohexen-1-one, 2-isopropyl-5-methyl- (7.6)
(1R,3S,6S)-3,7,7-Trimethylbicyclo[4.1.0]heptane (6.7)
2. Notes : Top note
3. 향기특성 : 신선하고 상쾌한 민트향, 약간 매운 맛의 멘톨향이 피부에 편안하고 시원한 느낌을 줌.
4. 향기치유 : 집중력향상, 활기와 원기회복, 새로운 영감제공, 집중력향상, 에너지증진, 활력증진
5. 치유효과 : 진통, 항염증, 항균, 항경련, 수렴, 구풍제, 부종완화, 혈액순환, 가래, 발열, 신경안정, 발한
6. 용도 : 아로마테라피, 향수, 바디용품, 바디케어(바디, 손), 두피관리, 홈케어, 항충제, 과자, 식품향, 구강제, 면도용 크림, 껌1. Appearance: Light yellow to yellow green liquid
2. Notes: Top note
3. Fragrance Characteristics: Fresh and refreshing mint scent, slightly spicy menthol scent gives a comfortable and cool feeling to the skin.
4. Fragrance Healing: Concentration improvement, vitality and vitality recovery, new inspiration, concentration improvement, energy promotion, vitality promotion
5. Healing effect: pain relief, anti-inflammatory, antibacterial, anticonvulsant, astringent, carminative, edema relief, blood circulation, phlegm, fever, nervous stability, sweating
6. Usage: Aromatherapy, perfume, body products, body care (body, hand), scalp care, home care, anti-fungal, confectionery, food flavor, mouthwash, shaving cream, gum
본 발명의 “생강(Zingiber officinale ROSC.)”은 생강과에 속하는 여러해살이풀로서 천연 에센셜 오일 추출은 생강뿌리를 증류추출하며 연노랑과 밝은 적갈색의 유동성 액체로 따뜻하지만 신선한 나무향과 약간 신선한 탑노트를 띤 매운향 그리고 언더톤의 달콤하고 진한 발삼향의 꽃향이 특징으로 각성작용 보온작용이 있다. 생강 에센셜 오일의 주요성분은 아래 표와 같으며 향기치유 효과로는 공포, 자포자기, 자신감이 결여되었을 때 자신감과 동기부여, 항조울증, 항불안, 항스트레스, 항우울증 등의 효과를 가지고 있다. 몸을 따뜻하게 해주어 감기 예방에 탁월하며, 혈관에 쌓인 콜레스테롤을 몸 밖으로 배출해 동맥경화나 고혈압 등 성인병 예방과 수족냉증, 복부냉증 해소에 도움이 되며 이뇨작용을 도와 부기를 제거 등 다양한 치유효과가 있다. "Ginger ( Zingiber officinale ROSC.)" of the present invention is a perennial plant belonging to the Zingiberaceae family. Natural essential oil extraction is distilled from ginger root, and is a light yellow and light reddish brown fluid liquid with a warm but fresh woody scent and a slightly fresh top note. It is characterized by a spicy scent and an undertone sweet and rich balsamic flower scent, which has an awakening effect and a warming effect. The main ingredients of ginger essential oil are shown in the table below. As for the aroma healing effect, it has effects such as confidence and motivation when fear, despair, and lack of confidence, anti-manic depression, anti-anxiety, anti-stress, and anti-depression. It warms the body and is excellent for preventing colds. It discharges cholesterol accumulated in the blood vessels out of the body to prevent adult diseases such as arteriosclerosis and high blood pressure, and helps to relieve cold hands and feet and cold stomach.
Camphene (3.9)
beta-Pinene (2.9)
(R)-Iisocarvestrene (3.6)
gamma-Terpinene (3.2)
Lavandulyl acetate (3.1)
alpha-Curcumene (4.7)
Italicene (4.4)
alpha-Zingiberene (8.0)
beta-Sesquiphellandrene (4.3)
Sesquisabinene hydrate (4.2)
2-Epi-alpha-cedrene (2.0)alpha-Pinene (2.5)
Camphene (3.9)
Beta-Pinene (2.9)
(R)-Iisocarbestrene (3.6)
gamma-Terpinene (3.2)
Lavandulyl acetate (3.1)
alpha-Curcumene (4.7)
Italicene (4.4)
alpha-Zingiberene (8.0)
beta-Sesquiphellandrene (4.3)
Sesquisabinene hydrate (4.2)
2-Epi-alpha-cedrene (2.0)
2. Notes : Top note
3. 향기특성 : 뜨겁고 톡 쏘는 매운향과 흙향의 달콤한 스파이스향, 활력을 주고 기분향상, 보온작용
4. 향기치유 : 자신감과 동기부여, 항조울증, 항불안, 항스트레스, 항우울증
5. 치유효과 : 신체기능 활성화, 피로회복, 멀미완화, 소화제, 혈액순환촉진, 거담제, 발한, 방부제, 가스배출, 항콜레스테롤, 항염증, 항바이러스, 항진균
6. 용도 : 아로마테라피, 약용, 향수, 향장, 향신료, 화장품(피부컨디셔닝), 오데코롱, 비누, 방향제, 양초1. Appearance: Yellowish liquid with gauze and viscosity
2. Notes: Top note
3. Fragrance Characteristics: Hot and pungent spicy scent and earthy sweet spice scent, invigorating, improving mood, warming effect
4. Fragrance Healing: Confidence and motivation, anti-manic, anti-anxiety, anti-stress, anti-depression
5. Healing effect: activation of physical functions, fatigue recovery, motion sickness relief, digestive, blood circulation promotion, expectorant, sweating, antiseptic, gas discharge, anti-cholesterol, anti-inflammatory, anti-viral, anti-fungal
6. Usage: Aromatherapy, medicine, perfume, incense, spice, cosmetics (skin conditioning), cologne, soap, air freshener, candle
본 발명의 “편백(Chamaecyparis obtusa (Siebold & Zucc.) Endl.)” 엽을 증류추출하여 얻어지는 에센셜 오일은 투명한 밝은 노랑색을 가진 오일로 Balsamic향과 파인의 향내음을 동시에 지닌 부드러운 테르핀 나무향이 상쾌한 숲속의 향기를 연상시키는 향이다. 편백엽 에센셜 오일의 주요성분은 아래 표와 같으며 피톤치드라는 천연 항균물질이 다량 함유되어 있어 심신안정, 항염증, 세룰라이트저감, 항스트레스, 피지억제, 항아토피, 항충, 항염, 소취제, 산림효과 등을 나타내는 다양한 용도로 활용되고 있다.The essential oil obtained by distilling and extracting the leaves of “cypress ( Chamaecyparis obtusa (Siebold & Zucc.) Endl. )” of the present invention is a transparent bright yellow oil with a balsamic scent and a pine scent at the same time. It is a scent reminiscent of the scent of The main components of cypress essential oil are shown in the table below. It contains a large amount of natural antibacterial substance called phytoncide, so it has a calming effect on mind and body, anti-inflammatory, cellulite reduction, anti-stress, sebum suppression, anti-atopic dermatitis, anti-inflammation, deodorant, and forest effect. It is used for a variety of purposes, such as
D-limonene (2.3)
4-carvomenthenol (3.3)
Bornyl acetate (2.1)
Camphene (5.6)
Thujopsene (3.7)
1-epi-bicyclosesquiphellandrene (2.6)
(+)-aromadendrene (2.3)
delta-cadinene (3.9)
alpha-Elemol (8.5)
Cedrol (5.1)
gamma-Eudesmol (7.3)
beta-Eudesmol (7.5)
Beyerene (4.3) beta-Phellandrene (2.1)
D-limonene (2.3)
4-carvomenthenol (3.3)
Bornyl acetate (2.1)
Camphene (5.6)
Thujopsene (3.7)
1-epi-bicyclosesquiphellandrene (2.6)
(+)-aromadendrene (2.3)
delta-cadinene (3.9)
alpha-Elemol (8.5)
Cedrol (5.1)
gamma-Eudesmol (7.3)
beta-Eudesmol (7.5)
Beyerene (4.3)
2. notes : Top-Middle note, Green/ Pine의 퍼퓸그룹
3. 향기특성 : Balsamic향과 파인의 향내음을 동시에 지닌 부드러운 테르핀 나무향의 상쾌한 숲속의 향기
4. 치유효과 : 항스트레스, 머리를 맑게하고 통증을 덜어주는 치유효과, 심신안정, 항염증, 세룰라이트저감, 항스트레스, 피지억제, 항아토피, 항충, 항염, 소취제, 산림효과
5. 용도 : 향수, 셀룰라이트저감, 숙면제, 거담제, 생활용품, 화장품, 공기정화제, 소취제, 방향제, 탈취제, 항충제1. Appearance: Transparent light brown
2. notes: Top-Middle note, Green/Pine perfume group
3. Fragrance Characteristics: Refreshing forest scent of soft terpine tree scent with balsamic scent and pine scent at the same time
4. Healing effect: Anti-stress, healing effect that clears the head and relieves pain, calms the mind and body, anti-inflammation, cellulite reduction, anti-stress, sebum inhibition, anti-atopy, anti-worm, anti-inflammation, deodorant, forest effect
5. Usage: Perfume, cellulite reduction, sleep aid, expectorant, household goods, cosmetics, air purifier, deodorant, air freshener, deodorant, anti-repellent
편백열매는 덜 성숙한 열매를 5~7월에 수확하여 에센셜 오일을 추출하며 편백열매 에센셜 오일의 주요성분은 아래 표와 같다. 향기특성으로는 Balsamic향과 파인의 향내음을 동시에 지닌 부드러운 테르핀 나무향이 상쾌한 숲속의 향기로 편백엽과 거의 동일한 치유효과를 가지나 편백엽의 에센셜 오일보다 다소 순한 효과를 가지는 것이 특징이다. 편백열매의 치유효과와 용도는 표에 제시하였다.Cypress fruit is harvested from immature fruits in May to July to extract essential oil. The main components of cypress fruit essential oil are shown in the table below. As for the scent characteristics, the soft terpine tree scent with the scent of balsamic and pine at the same time is a refreshing scent in the forest. The healing effects and uses of cypress berries are presented in the table.
sabinene (4.3)
beta-Pinene (2.7)
alpha-Terpinene (2.1)
4-Ethyl-m-xylene (2.6)
gamma-Terpinene (3.6)
Terpinolene (4.3)
4-carvomenthenol (5.9)
laevo-bornyl acetate (3.3)
Camphene (5.7)
Thujopsene (2.7)
alpha-Elemol (7.6)
Cedrol (2.3)
gamma-eudesmol (6.0)
beta-Eudesmol (5.1)alpha-Pinene (5.0)
sabinene (4.3)
Beta-Pinene (2.7)
alpha-Terpinene (2.1)
4-Ethyl-m-xylene (2.6)
gamma-Terpinene (3.6)
Terpinolene (4.3)
4-carvomenthenol (5.9)
laevo-bornyl acetate (3.3)
Camphene (5.7)
Thujopsene (2.7)
alpha-Elemol (7.6)
Cedrol (2.3)
gamma-eudesmol (6.0)
beta-Eudesmol (5.1)
2. notes : Top-Middle note, Green/ Pine의 퍼퓸그룹
3. 향기특성 : Balsamic향과 파인의 향내음을 동시에 지닌 부드러운 테르핀 나무향의 상쾌한 숲속의 향기
4. 치유효과 : 항스트레스, 머리를 맑게하고 통증을 덜어주는 치유효과, 심신안정, 항염증, 세룰라이트저감, 항스트레스, 피지억제, 항아토피, 항충, 항염, 소취제, 산림효과 등
5. 용도 : 향수(중성, 남성), 셀룰라이트저감, 숙면제, 거담제, 생활용품, 공기정화제, 소취제, 방향제, 탈취제, 맛사지 오일1. Appearance: Transparent light brown
2. notes: Top-Middle note, Green/Pine perfume group
3. Fragrance Characteristics: Refreshing forest scent of soft terpine tree scent with balsamic scent and pine scent at the same time
4. Healing effect: Anti-stress, healing effect that clears the head and relieves pain, calms the mind and body, anti-inflammation, cellulite reduction, anti-stress, sebum inhibition, anti-atopy, anti-worm, anti-inflammation, deodorant, forest effect, etc.
5. Use: perfume (neutral, male), cellulite reduction, sleep aid, expectorant, household goods, air purifier, deodorant, air freshener, deodorant, massage oil
본 발명의 "스윗오렌지(Citrus sinensis)" 에센셜 오일은 달콤하고 신선한 향을 나타내며 에센셜 오일의 주요성분은 아래 표와 같다. 오렌지 에센셜 오일은 정체된 기의 흐름 작용을 도와 히스테리나 정신적 긴장, 피로를 해소하고 우울증을 완화효과가 있다. 또한 피부세포의 재생 및 항노화 효과가 있으며 소화계의 내장 연동운동을 정상화하여 항변비, 배뇨촉진 효과가 있으며 담즙 분비 촉진 및 지방대사 촉진 효과가 알려져 있다. 특히 본 발명과 관련이 깊은 치유효과로 림프 흐름을 자극하여 림프부종 치료, 노폐물 제거, 셀룰라이트 분해에 효과가 있어 다른 오일과 블렌딩하여 셀룰라이트 처치제로 사용되고 있다.The "sweet orange ( Citrus sinensis )" essential oil of the present invention has a sweet and fresh scent and the main components of the essential oil are shown in the table below. Orange essential oil helps the flow of stagnant energy, relieves hysteria, mental tension, fatigue, and relieves depression. In addition, it has skin cell regeneration and anti-aging effects, normalizes intestinal peristalsis of the digestive system, has anti-constipation and urination promoting effects, and is known to promote bile secretion and fat metabolism. In particular, it is effective in treating lymphedema, removing waste products, and decomposing cellulite by stimulating lymph flow with a healing effect closely related to the present invention, and is used as a cellulite treatment agent by blending with other oils.
Alpha-Pinene (2.3)
Beta-pinene (3.2)
Myrcene (5.5)
sabinene (6.2)
D-limonene (27.4)
Limonene (13.1)D-alpha-pinene (2.2)
Alpha-Pinene (2.3)
Beta-pinene (3.2)
Myrcene (5.5)
sabinene (6.2)
D-limonene (27.4)
Limonene (13.1)
2. notes : Top note
3. 향기특성 : 달콤하고 신선한 감귤향, 따듯하고 톡 쏘는 오렌지 향이 생기와 기분을 돋우며 심신을 밝고 활력을 줌
4. 치유효과 : 정신고양, 항우울, 정신피로회복, 항불안, 신경강화, 위장기능강화, 장내가스배출, 통증완화, 항바이러스, 항염, 피부재생, 공기정화
5. 용도 : 아로마테라피, 약용, 향수, 식품향료, 스킨케어(피지조절), 차, 주류, 과자, 음료, 방향제, 소취제, 세정제1. Appearance: Orange transparent liquid
2. notes: Top notes
3. Fragrance Characteristics: Sweet and fresh citrus scent, warm and tangy orange scent boosts vitality and mood, brightens and energizes the mind and body.
4. Healing effect: Mental uplift, antidepressant, mental fatigue recovery, antianxiety, nerve strengthening, gastrointestinal function enhancement, intestinal gas discharge, pain relief, antiviral, anti-inflammatory, skin regeneration, air purification
5. Usage: Aromatherapy, medicinal use, perfume, food flavoring, skin care (sebum control), tea, alcoholic beverages, snacks, beverages, air fresheners, deodorants, detergents
본 발명의 "레몬(Citrus limon)"은 운향과의 상록성 교목으로, 과피로부터 에센셜 오일을 추출하며 과즙은 주로 식품이나 화장품 등의 원료로 사용된다. 레몬 에센셜 오일의 주요성분은 아래 표와 같으며 가볍고 신선하며 달콤한 향기를 갖고 있어 집중력을 높이고 기분을 고양시켜 긍정적 마인드를 갖는 아로마 효과가 있다. 레몬 에센셜 오일의 항바이러스성은 면역력을 강화시키고, 혈액의 점성을 낮추어 동맥내 혈소판 침적물 분쇄, 콜레스테를 감소로 인한 혈관강화 효과와 피부의 미백, 항노화 효과가 있다. 특히 림프계의 해독작용이 있어 독혈증 또는 셀룰라이트의 치료제로 피부마사지에서 다른 오일과 혼합하여 활용되고 있다. "Lemon ( Citrus limon )" of the present invention is an evergreen tree of the family Rutaceae, and extracts essential oil from the skin, and the juice is mainly used as a raw material for food or cosmetics. The main components of lemon essential oil are shown in the table below. It has a light, fresh and sweet scent, so it has an aroma effect with a positive mind by increasing concentration and enhancing mood. The antiviral properties of lemon essential oil strengthen immunity, lower blood viscosity, crush platelet deposits in arteries, strengthen blood vessels by reducing cholesterol, and have skin whitening and anti-aging effects. In particular, it has a detoxifying effect on the lymphatic system, so it is used in combination with other oils in skin massage as a treatment for toxemia or cellulite.
alpha-Pinene (6.7)
beta-pinene (17.0)
sabinene (3.3)
D-limonene (15.3)
Limonene (7.9)
gamma-terpinene (4.9)
Citral (2.1)
Neryl acetate (3.1)D-alpha-pinene (3.7)
alpha-Pinene (6.7)
beta-pinene (17.0)
sabinene (3.3)
D-limonene (15.3)
Limonene (7.9)
gamma-terpinene (4.9)
Citral (2.1)
Neryl acetate (3.1)
2. notes : Top note
3. 향기특성 : 산뜻한 레몬향, 감규류의 알데히드 테르펜 향기, 시트러스의 강력하고 향긋한 향기가 생기와 기분을 돋움
4. 치유효과 : 정신고양, 정신피로회복, 항스트레스, 피부(수렴, 해독), 집중력향상, 면역강화, 통증완화, 항균, 항바이러스, 피지분비조절
5. 용도 : 아로마테라피, 맛사지(셀룰라이트, 미백), 약용, 향수, 화장품, 스킨케어, 조미료, 향신료, 식품향료, 홈케어(방향제, 세정제, 소취제)1. Appearance: Transparent yellow liquid
2. notes: Top notes
3. Fragrance Characteristics: Refreshing lemon scent, aldehyde terpene scent of citrus, and strong and fragrant scent of citrus stimulates the mood.
4. Healing effect: Mental enhancement, mental fatigue recovery, anti-stress, skin (convergence, detoxification), concentration improvement, immunity enhancement, pain relief, antibacterial, antiviral, sebum secretion control
5. Use: Aromatherapy, massage (cellulite, whitening), medicine, perfume, cosmetics, skin care, seasoning, spice, food flavoring, home care (air freshener, detergent, deodorant)
본 발명의 "로즈마리(Rosmarinus officinalis)" 전초로부터 추출한 에센셜 오일은 투명한 미황색을 띠는 오일로 강하고 신선한 나무향을 띠는 풀향의 톱노트에 깨끗한 나무향과 발삼향의 바디노트를 가지며 베이스노트로 마른 풀향을 가지는 향기특성이 있다. 로즈마리는 수세기동안 의약용으로 이용됐으며 정신 자극효과와 유용한 기억보조제로 집중력 부족과 신경쇠약 치유제로 이용되었다. 로즈마리 에센셜 오일의 주요 성분은 아래 표와 같으며 간과 쓸개의 기능 강화, 피부재생, 심혈관 강화, 항균 등의 효과가 있으며 피부재생, 탄력강화 등 고품질 피부관리에 혼합되는 오일이다.The essential oil extracted from the outpost of " Rosmarinus officinalis " of the present invention is a transparent pale yellow oil with a strong, fresh, woody, grassy top note, a clean woody scent and a balsamic body note, and a dry base note. It has a scent characteristic with a grassy scent. Rosemary has been used medicinally for centuries and has been used as a psychostimulant, useful memory aid, and remedy for concentration problems and nervous breakdowns. The main ingredients of rosemary essential oil are shown in the table below. It has effects such as strengthening liver and gallbladder functions, skin regeneration, strengthening cardiovascular system, and antibacterial.
Camphene (3.4)
beta-Pinene (2.5)
Myrcene (2.7)
alpha-Terpinene (2.6)
D-limonene (5.5)
gamma-Terpinene (2.1)
Terpinolene (2.4)
Linalool (3.2)
(±)-camphor (2.9)
Isoborneol (5.0)
Geraniol (5.9)
Bornyl acetate (4.4)
Trans-beta-Caryophyllene (4.5)alpha-Pinene (8.4)
Camphene (3.4)
Beta-Pinene (2.5)
Myrcene (2.7)
alpha-Terpinene (2.6)
D-limonene (5.5)
gamma-Terpinene (2.1)
Terpinolene (2.4)
Linalool (3.2)
(±)-camphor (2.9)
Isoborneol (5.0)
Geraniol (5.9)
Bornyl acetate (4.4)
Trans-beta-Caryophyllene (4.5)
2. Notes : Middle note
3. 향기특성 : 장뇌향과 신선한 우디 발사믹향과 약초향 등이 신경조직에 쉽게 파고들어 활력을 줌, 달콤하고 쌉사름한 자극, 시원하고 개운한 느낌의 릴렉스 효과
4. 치유효과 : 기억력 및 집중력 향상, 정신고양, 항우울, 통증완화(류마티스, 관절염, 근육통), 저혈압, 혈행촉진(수족냉증, 빈혈개선), 기침, 기관지염, 두피개선, 항산화, 독소배출, 항균, 항염, 방충, 소취작용
5. 용도 : 아로마테라피, 육류부패방지, 향신료(육류, 생선), 스파, 향수, 화장품, 방향제, 피부마사지용, 비누, 헤어토닉, 홈케어, 허브차, 포프리, 리스, 과자, 데코레이션1. Appearance: Transparent yellow
2. Notes: Middle note
3. Fragrance Characteristics: Camphor scent, fresh woody balsamic scent, and herbal scent easily penetrate into nerve tissue and give vitality, sweet and bitter stimulation, and cool and refreshing feeling of relaxation effect
4. Healing effect: improvement of memory and concentration, mental enhancement, antidepressant, pain relief (rheumatism, arthritis, muscle pain), low blood pressure, blood circulation promotion (improvement of cold hands and feet, anemia), cough, bronchitis, scalp improvement, antioxidant, toxin discharge, Antibacterial, anti-inflammatory, insect repellent, deodorizing action
5. Usage: Aromatherapy, meat spoilage prevention, spices (meat, fish), spa, perfume, cosmetics, air freshener, skin massage, soap, hair tonic, home care, herbal tea, poppy, lease, snacks, decoration
본 발명의 "로즈제랴늄(Pelargonium graveolens)”은 전초에서 증류추출한 에센셜 오일로서 녹색의 올리브색, 풀잎냄새와 장미향을 갖고 있어 세제, 크림, 로션, 향수 등 광범위하게 사용되고 있다. 로즈제라늄 에센셜 오일의 주요성분은 아래 표와 같으며 정신 평온, 좌절과 초초함을 없애주며 생리전 긴장과 폐경기 증상 완화에 도움을 주며 스트레스 저감, 항우울에 효과가 있다. 또한 이뇨성과 림프계 촉진효과로 셀룰라이트, 체액정체 치료에 유용하며 피부세포 재생력이 우수하여 항노화, 항염증, 피지생성 조절로 피부관리에서 가장 선호하는 혼합용으로 사용하는 아로마오일이다.The "Rose Geranium ( Pelargonium graveolens )" of the present invention is an essential oil distilled from the outpost, and has a green olive color, grass smell and rose scent, and is widely used in detergents, creams, lotions, perfumes, etc. Main of Rose Geranium essential oil Ingredients are listed in the table below, and it eliminates mental calmness, frustration and nervousness, helps to relieve premenstrual tension and menopausal symptoms, is effective in stress reduction and antidepression, and treats cellulite and body fluid retention with diuretic and lymphatic system promoting effects. It is useful for skin cell regeneration and has excellent skin cell regeneration, anti-aging, anti-inflammation, and control of sebum production.
Citronellol (2.6)
6,7-dihydrogeraniol (3.4)
(R)-(+)-beta-citronellol (2.6)
(R)-(+)-Citronellic acid (2.7)
Guaia-3,7-diene (3.0)
neo-Alloocimene (2.6)
Geranyl propionate (2.2)
Phenethyl tiglate 1 (2.5)
8-epi-gama-Eudesmol (4.7)
Geranyl tiglate (3.5)
geranyl 2-methyl butyrate (3.3)Linalool (5.3)
Citronellol (2.6)
6,7-dihydrogeraniol (3.4)
(R)-(+)-beta-citronellol (2.6)
(R)-(+)-Citronellic acid (2.7)
Guaia-3,7-diene (3.0)
neo-Allocimene (2.6)
Geranyl Propionate (2.2)
Phenethyl tiglate 1 (2.5)
8-epi-gama-Eudesmol (4.7)
Geranyl tiglate (3.5)
geranyl 2-methyl butyrate (3.3)
2. notes : Middle note
3. 향기특성 : 신선한 녹색의 달콤한 장미꽃향, 비릿한 풀냄새와 장미왁스 같은 시트러스 향이 섞인 약초향
4. 향기치유 : 기분완화, 긍정부여, 평온한 자연의 향기가 편안함 부여로 기분 고양, 심신 균형 유지
5. 치유효과 : 아로마테라피(항우울, 신경불안, 진정), 통증경감, 항염증. 여성호르몬조절, 해독, 신경균형, 피부연화, 혈행촉진, 살균, 방취, 지혈, 강장, 이뇨
6. 용도 : 고급향수, 식품향료(디저트, 캐이크, 젤리), 차, 화장품, 방향제, 목욕제, 헤어용품, 항충제1. Appearance: Opaque pale yellow liquid
2. Notes: Middle notes
3. Fragrance Characteristics: Fresh green sweet rose flower scent, fishy grass scent and herbal scent mixed with rose wax-like citrus scent
4. Fragrance Healing: Relieves mood, gives positivity, enhances mood and maintains mind-body balance with the scent of tranquil nature giving comfort
5. Healing effect: Aromatherapy (antidepressant, nervous anxiety, sedation), pain relief, anti-inflammation. Female hormone regulation, detoxification, nervous balance, skin softening, blood circulation promotion, sterilization, deodorization, hemostasis, tonic, diuretic
6. Usage: High-quality perfume, food flavoring (dessert, cake, jelly), tea, cosmetics, air freshener, bath agent, hair products, antiseptic
상기 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 편백종자 오일, 동백종자 오일, 세서미종자 오일, 커피그린빈 오일 및 해바라기씨 오일을 포함하는 베이스 오일 및 Vitamin E, 스쿠알란(Squalane), 이데베논(Idebenone), 유자씨추출액을 포함하는 기능성 첨가제를 더 포함할 수 있다. The aromatherapy composition for psychological stability and cellulite reduction is a base oil including cypress seed oil, camellia seed oil, sesame seed oil, coffee green bean oil and sunflower seed oil, and Vitamin E, squalane, and idebenone. , A functional additive containing citron seed extract may be further included.
상기 베이스 오일은 에센셜 오일의 휘발을 억제하고, 농도를 희석해 주며 피부 마사지할 때 손가락의 유연성을 돕고 피부의 물리적 자극을 통해 림프계 및 자율신경계를 자극하여 피로회복, 노페물 배출, 수면을 취하도록 도와주는 역할을 하여, 에센셜 오일의 효능을 높일 수 있다.The base oil suppresses volatilization of essential oil, dilutes the concentration, helps finger flexibility when massaging the skin, and stimulates the lymphatic system and autonomic nervous system through physical stimulation of the skin to help recover from fatigue, discharge waste products, and sleep. By playing a role in giving, the efficacy of essential oils can be increased.
에센셜 오일과 베이스 오일을 혼합하여 전신 또는 부분 피부마사지, 또는 화장료 조성물로 활용하면 에센셜 오일의 성분과 베이스 오일의 영양성분 등이 85% 정도가 체내 세포조직에 흡수되어 보다 빠르게 총체적인 치유효과를 나타낸다. 그 이유는 에센셜 오일 성분은 지방에 잘 용해되는 성분으로 중추신경계와 같이 지방이 풍부한 조직에 신속히 도달하여 뇌의 특정 영역을 자극해 치유효과를 나타내며 흡수된 베이스 오일의 영양성분과 복합적으로 상승작용하여 필요한 부위에 효과적으로 에너지를 전달할 수 있다. When essential oil and base oil are mixed and used as a whole body or partial skin massage or cosmetic composition, about 85% of the essential oil and nutrient components of the base oil are absorbed into the body's tissue, resulting in a faster overall healing effect. The reason for this is that essential oil components are easily soluble in fat, so they quickly reach fat-rich tissues such as the central nervous system and stimulate specific areas of the brain to have a healing effect. Energy can be delivered effectively to the required area.
100% 순수 에센셜 오일은 고농도이며 입자가 매우 미세하여 피부의 흡수율이 매우 높아 체내에 흡수되면 곧바로 화학계통과 상호작용을 하여 약리성이 강해져 부작용이 일어날 수 있다. 순수한 에센셜 오일은 반드시 희석해서 사용해야 피부의 부작용을 예방하고 안전하게 사용할 수 있는데, 이때 단독 또는 여러 종류를 혼합한 에센셜 오일을 사용할 경우 적정 농도로 희석해 주고 에센셜 오일과 상호보완 작용을 하여 치유효과와 피부미용 효과를 동시에 높여주는 것이 베이스 오일(Base oil)이다. 베이스 오일 대부분 식물의 견과류나 씨앗에서 추출하며 조금씩 다른 성분을 갖고 있기 때문에 피부의 상태에 따라 또는 에센셜 오일의 치유 목적에 따라 알맞게 선택해서 사용하는 것이 중요하다.100% pure essential oil is highly concentrated and the particles are very fine, so the absorption rate of the skin is very high. Pure essential oils must be diluted to prevent side effects on the skin and be used safely. At this time, when using essential oils alone or in combination with several types, dilute them to the appropriate concentration and complement each other with essential oils to achieve healing effects and skin Base oil enhances the beauty effect at the same time. Most of the base oils are extracted from nuts or seeds of plants and have slightly different components, so it is important to select and use them according to the condition of the skin or the purpose of healing essential oils.
본 발명에서 베이스 오일은 피부 또는 바디 마사지에서 필수오일이며 크림과 같은 화장품 원료로 대량 사용되는 오일로서 단독 또는 에센셜 오일과 혼합하여 사용하는데 림프드레나쥐 및 일반 마사지 요법 등에 적용하여 사용할 경우 마사지하는 손가락의 움직임을 매끄럽게 하여 유연성을 높이고 손 마사지는 피부에 반복적인 물리적 충격을 주어 피부속으로 흡수된 마사지오일의 치유성분이 빠른 효과를 나타내도록 림프계를 적극적으로 자극하는 역할을 한다. In the present invention, the base oil is an essential oil for skin or body massage and is used in large quantities as a raw material for cosmetics such as cream. It is used alone or mixed with essential oil. It increases flexibility by smoothing movements, and hand massage plays a role in actively stimulating the lymphatic system by giving repeated physical shocks to the skin so that the healing ingredients of massage oil absorbed into the skin show a quick effect.
본 발명의 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 피부미용 또는 부분, 전신 마사지오일로 사용할 수 있으며 림프드레나쥐와 같은 손 마사지 기법을 적용하여 마사지를 할 경우 아로마 에센셜 오일의 성분과 베이스 오일의 영양성분 등이 효율적으로 피부에 흡수시켜 체내의 혈액순환이나 림프순환의 흐름을 원활하게 하고 셀룰라이트와 독성 노폐물 등은 분해시켜 체외배출을 촉진시켜 조직의 영양대사 장애를 개선시키고 에센셜 오일의 향기성분이 자율신경계의 항상성과 균형을 유지시켜 스트레스 완화 및 피로를 풀어주어 미용증진과 건강한 몸매를 가꾸어 주는 전인적인 심신 치유효과를 기대할 수 있도록 개발한 것이 특징이다. The aromatherapy composition for psychological stability and cellulite reduction of the present invention can be used as skin care or partial or whole body massage oil. Nutrients are efficiently absorbed into the skin to facilitate the flow of blood and lymph circulation within the body, and cellulite and toxic wastes are decomposed and excreted from the body to promote excretion to improve tissue nutrient metabolism disorders and aroma components of essential oils. It is characterized by the fact that it was developed so that you can expect a holistic mind and body healing effect that promotes beauty and maintains a healthy body by relieving stress and fatigue by maintaining the homeostasis and balance of the autonomic nervous system.
본 발명에서는 아로마테라피 효능을 극대화시킬 수 있는 베이스 오일을 선택하여 조합한 후 아로마 에센셜 오일의 조성물과 적정배율로 배합하여 피부효능과 오일조성물의 장기 저장성을 높여주는 기능성 첨가물을 첨가하여 최종 심신 치유형 셀룰라이트 저감 아로마테라피 향장료 조성물을 완성하였다.In the present invention, after selecting and combining base oils that can maximize aromatherapy efficacy, they are combined with the composition of aroma essential oils in an appropriate ratio to add functional additives that increase skin efficacy and long-term storage of oil compositions to form a final mind-body healing type. A cellulite-reducing aromatherapy cosmetic composition was completed.
본 발명의 “편백(Chamaecyparis obtusa (Siebold & Zucc.) Endl.)”은 한국과 일본에서 자생하는 침엽계의 상록교목으로 국내에는 전남이 전국의 80% 이상을 차지하고 있다. 6~7월 미성숙 편백 종자를 증류추출하여 얻어지는 오일은 투명한 엷은 노랑색을 띠며 녹색 우디 달콤한 향과 흙냄새가 섞인 신선한 침엽수향이 난다. 편백종자의 에센셜 오일의 주요 화학성분은 알파-엘레몰(alpha-Elemol), 알파-유데스몰(gamma-eudesmol), 4-카보멘테놀(4-carvomenthenol), 캄펜(Camphene), 베타 유데스몰(beta-Eudesmol, 알파-피넨(alpha-Pinene), 사비넨(sabinene), 테르피놀렌(Terpinolene), 감마-테르펜(gamma-Terpinene), 라에보-보르닐 아세테이트(laevo-bornyl acetate), 베타-피넨(beta-Pinene), 투잡젠(Thujopsene), 세드롤(Cedrol), 알파-테르피넨(alpha-Terpinene) 등이었다. 편백종자 에센셜 오일은 모노 및 세스퀴테르펜과 약용성분 등을 함유하여 항균, 항산화, 방관, 신장 이뇨 및 독성배출 촉진, 항염증 효과가 있으며 진정작용 및 스트레스 완화 효과, 불면증 해소 등의 효과가 있다. 특히 투잡젠(Thujopsene)은 당뇨병과 같은 대사질환을 유발하지 않는 항비만 효과와 Cedrol 은 콜라겐과 엘라스틴의 생산 증가로 노화방지 효과가 있다. " Chamaecyparis obtusa (Siebold & Zucc.) Endl. )" of the present invention is an evergreen tree of the conifer family native to Korea and Japan, and Jeonnam accounts for more than 80% of the country in Korea. The oil obtained by distilling and extracting immature cypress seeds in June-July has a transparent pale yellow color and has a fresh coniferous scent mixed with a green woody sweet scent and an earthy smell. The main chemical components of essential oil of cypress seeds are alpha-Elemol, gamma-eudesmol, 4-carvomenthenol, camphene, and beta-eudesmol. Mol (beta-Eudesmol, alpha-Pinene, sabinene, Terpinolene, gamma-Terpinene, laevo-bornyl acetate, They were beta-Pinene, Thujopsene, Cedrol, alpha-Terpinene, etc. Cypress seed essential oil contains mono and sesquiterpenes and medicinal ingredients, It has antibacterial, antioxidant, antibacterial, kidney diuretic and toxic excretion, anti-inflammatory, sedative and stress relieving effects, insomnia relief, etc. In particular, Thujopsene is an antioxidant that does not cause metabolic diseases such as diabetes. Anti-obesity effect and Cedrol have an anti-aging effect by increasing the production of collagen and elastin.
본 발명의 "동백(Camellia japonica L.)" 우리나라 전역에서 자라나 주로 남부도서해안에서 자생하는 상록교목으로 동백종자로부터 냉압착 오일추출하여 얻는다. 동백오일은 예로부터 여성의 머릿기름으로 사용한 전통오일로서 보습에 우수한 올레인산이 풍부하게 함유돼 있어 피부 보습과 진정에 좋은 효능을 가지며, 항산화, 항노화, 항염, 미백, 항주름 및 항알러지 작용을 한다." Camellia japonica L. " of the present invention is an evergreen tree that grows throughout Korea and is mainly native to the southern island coast, and is obtained by cold-pressing oil extraction from camellia seeds. Camellia oil is a traditional oil that has been used as a hair oil for women since ancient times. It is rich in oleic acid, which is excellent for moisturizing, so it has good effects on moisturizing and soothing the skin, and has antioxidant, anti-aging, anti-inflammatory, whitening, anti-wrinkle and anti-allergic effects. .
본 발명의 "세서미(Sesamum Indicum)" 오일은 세포를 회복시키고, 혈액순환을 돕는 피부 미용제이며, 주성분으로는 올레인산, 리놀산을 함유하고 있다. 그 외에 비타민 E, 칼슘, 마그네슘, 인 등이 풍부하고, 산화를 막는 성분인 세사몰, 세사모리놀 등을 함유하고 있다. 또한 산화를 방지하는 세사몰, 세사모리놀 성분은 노화나 암을 유발시키는 과산화지질을 억제하는 효능이 있다고 알려져 있고 천연 수분 공급과 자외선차단원으로서 피부관리의 베이스 오일로 사용되고 있으며 다른 베이스 오일과 블랜딩할 경우 오일의 저장 수명을 늘려준다. The "sesame ( Sesamum Indicum )" oil of the present invention is a skin beauty agent that restores cells and helps blood circulation, and contains oleic acid and linoleic acid as main components. In addition, it is rich in vitamin E, calcium, magnesium, and phosphorus, and contains sesamol and sesaminol, which are components that prevent oxidation. In addition, sesamol and sesaminol components, which prevent oxidation, are known to have the effect of suppressing lipid peroxide, which causes aging or cancer, and are used as a base oil for skin care as a source of natural moisture and sun protection, and are blended with other base oils. Doing so will increase the shelf life of the oil.
본 발명의 "커피그린빈(Coffea arabica bean)" 오일은 볶지 않는 커피콩에서 냉압착한 오일로 식물성 리놀레산(Linoleic acid)과 팔미트산(Palmitic acid)의 에스테르(Esters), 디터펜 성분의 카페스톨과 카웨올, 인지질 등의 지질 성분이 풍부하고 산화 방지효과가 있어 주름개선, 부종(비만), 습진, 건성 등의 치유효과가 있다. 생두의 풍부한 클로로겐산(chlorogenic acid)은 지방을 연소시키고 신지대사를 활발하게 하는 효능이 있고 식물성 스테롤(피토스테롤)은 피부장벽을 건강하고 탄력을 주는 효능이 있다. The " coffea arabica bean" oil of the present invention is cold-pressed oil from unroasted coffee beans, and contains esters of vegetable linoleic acid and palmitic acid, cafestol of diterpene. It is rich in lipid components such as, kweol, and phospholipids, and has antioxidant effects, so it has healing effects such as wrinkle improvement, edema (obesity), eczema, and dryness. Chlorogenic acid, which is abundant in green beans, has the effect of burning fat and activating new metabolism, and plant sterols (phytosterols) have the effect of making the skin barrier healthy and elastic.
본 발명의 "해바라기(Heliamthus Annuusl) 씨" 오일은 리놀레익산이 50%이상 함유되어 있으며 필수지방산, 비타민 A, B, D, E 등과 칼슘, 아연, 칼륨, 철, 인과 같은 무기물 함량이 풍부하다. 지루성 피부에 좋으며 보습효과, 피부를 맑게 하는 효과가 있고 항노화, 항주름 효과가 있다. 오메가6지방산 및 식물성 피토스테롤 성분이 풍부하여 우리몸의 콜레스테롤을 낮춰주고 혈액순환을 도와 성인병 예방효과, 셀레늄 성분 함유로 활성산소 제거와 항암효과를 가진다.The "sunflower ( Heliamthus Annuusl ) seed" oil of the present invention contains more than 50% of linoleic acid and is rich in essential fatty acids, vitamins A, B, D, E and other minerals such as calcium, zinc, potassium, iron and phosphorus. . It is good for seborrheic skin, has a moisturizing effect, clears the skin, and has anti-aging and anti-wrinkle effects. Rich in omega-6 fatty acids and plant phytosterols, it lowers cholesterol in the body and helps blood circulation, preventing adult diseases, and containing selenium, which has active oxygen removal and anticancer effects.
상기 베이스 오일의 편백종자는 증류추출법으로 동백종자, 세서미종자는 냉압착추출하였으며 커피그린빈과 해바라기씨 오일은 냉압착하여 판매되고 있는 종실오일을 사용하였다. Cypress seeds of the base oil were cold-pressed and extracted from camellia seeds and sesame seeds by distillation extraction, and coffee green bean and sunflower seed oils were cold-pressed and commercially available seed oil was used.
상기 기능성 첨가제는 상기 아로마테라피 조성물의 산화 및 산패방지를 하여 오일의 장기저장, 피부흡수촉진, 항노화, 피부재생, 노페물과 독소를 배출하는 효과를 제공한다. The functional additive provides effects of long-term storage of oil, promotion of skin absorption, anti-aging, skin regeneration, and discharge of waste and toxins by preventing oxidation and rancidity of the aromatherapy composition.
상기 베이스 오일, 에센셜 오일 및 기능성 첨가제를 포함하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물은 베이스 오일 74 ~ 98 중량%, 에센셜 오일 1 ~ 21 중량% 및 기능성 첨가제 1 ~ 5중량%를 포함할 수 있다. The aromatherapy composition for psychological stability and cellulite reduction comprising the base oil, essential oil and functional additives may include 74 to 98% by weight of the base oil, 1 to 21% by weight of the essential oil and 1 to 5% by weight of the functional additives. there is.
본 발명자의 실험에 의하면, 본 발명의 실시예에서는 베이스 오일 81중량%, 에센셜 오일 14중량% 및 기능성 첨가제 5중랑%로 포함하는 경우 신선한 감귤향기, 기분 좋은 허브향기 및 약한 침엽향이 섞인 향을 지니고 있어 마음의 긍정적인 활력을 주나 안정감과 편안함을 주는 효과가 있으며 마사지후 유연성, 보습성, 릴렉싱 효과가 적정하다는 평가가 있었다.According to the experiment of the present inventors, in the embodiment of the present invention, when 81% by weight of base oil, 14% by weight of essential oil, and 5% by weight of functional additives are included, a fresh citrus scent, a pleasant herbal scent, and a weak needle scent are mixed. It has the effect of giving positive vitality to the mind, but also gives a sense of stability and comfort, and it has been evaluated that flexibility, moisturizing and relaxing effects after massage are appropriate.
본 발명의 다른 실시예에 따르면, 편백종자 오일, 동백종자 오일, 세서미종자 오일, 커피그린빈 오일 및 해바라기씨 오일을 혼합하여 베이스 오일을 제조하는 단계; 참당귀 오일, 유자 오일, 박하 오일, 생강 오일, 편백엽 오일, 로즈마리 오일, 로즈제랴늄 오일, 스윗오렌지 오일, 레몬 오일을 혼합하여 에센셜 오일을 제조하는 단계; Vitamin E, 스쿠알란(Squalane), 이데베논(Idebenone), 유자씨추출액을 포함하는 기능성 첨가제를 제조하는 단계;및 상기 베이스 오일, 에센셜 오일 및 기능성 첨가제를 혼합하는 단계를 포함하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물 제조방법을 제공한다. According to another embodiment of the present invention, preparing a base oil by mixing cypress seed oil, camellia seed oil, sesame seed oil, coffee green bean oil and sunflower seed oil; Preparing an essential oil by mixing angelica oil, citron oil, mint oil, ginger oil, cypress oil, rosemary oil, rose geranium oil, sweet orange oil, and lemon oil; Preparing functional additives including Vitamin E, Squalane, Idebenone, and citron seed extract; and psychological stability and cellulite reduction including mixing the base oil, essential oil and functional additives. It provides a method for preparing an aromatherapy composition for use.
상기 베이스 오일, 에센셜 오일 및 기능성 첨가제를 혼합하는 단계는 베이스 오일 74 ~ 98 중량%, 에센셜 오일 1 ~ 21 중량% 및 기능성 첨가물 1 ~ 5중량%를 혼합할 수 있으나, 이에 제한되는 것은 아니다. In the mixing of the base oil, essential oil and functional additives, 74 to 98% by weight of the base oil, 1 to 21% by weight of the essential oil, and 1 to 5% by weight of the functional additive may be mixed, but is not limited thereto.
상기 베이스 오일에 혼합하는 종자 오일을 제조하기 위하여 각기 제철에 나는 열매를 수확하여 열매의 외피(outer skin)를 제거한 각각의 종실별로 준비한 후 세척하여 증류추출기인 내솥의 총용량에 대한 60%의 종실과 정제수 40%를 넣어 30~60분 정도 삶아낸 종실을 건조시켜 종피를 제거하여 순수한 씨앗을 냉압착 추출하여 생산된 동백씨 오일, 세서미종자 오일과 편백열매를 증류추출하여 얻은 편백열매 오일, 이미 냉압착하여 제조된 커피그린빈 오일, 해바라기씨 오일을 구하여 이들 오일들을 혼합하여 베이스 오일 조성물을 제조할 수 있다.In order to prepare seed oil to be mixed with the base oil, fruits produced in each season are harvested, the outer skin of the fruit is removed, and each seed is prepared, washed, and 60% of the total capacity of the inner pot, which is a distillation extractor, Seeds boiled in 40% purified water for 30 to 60 minutes are dried, seed coats are removed, and camellia seed oil produced by cold-pressing extraction of pure seeds, cypress fruit oil obtained by distilling sesame seed oil and cypress fruit, A base oil composition can be prepared by obtaining coffee green bean oil and sunflower seed oil prepared by pressing and mixing these oils.
상기 제조된 혼합물에 참당귀, 유자, 박하, 생강, 편백옆, 로즈마리, 로즈제라늄, 스윗오렌지, 레몬으로부터 추출한 각각의 에센셜 오일을 증류추출하여 얻어진 에센셜 오일을 혼합하여 셀룰라이트 저감 아로마테라피 향장료 조성물을 제조할 수 있다.A cellulite-reducing aromatherapy cosmetic composition by mixing essential oils obtained by distilling each essential oil extracted from donkey, citron, mint, ginger, cypress, rosemary, rose geranium, sweet orange, and lemon into the mixture prepared above. can be manufactured.
이하, 실시예를 통하여 본 발명의 구성 및 효과를 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위가 이들 실시예에 의해 한정되는 것은 아니다.Hereinafter, the configuration and effects of the present invention will be described in more detail through examples. These examples are only for illustrating the present invention, and the scope of the present invention is not limited by these examples.
1. 에센셜 오일 추출1. Essential Oil Extraction
(1) 에센셜 오일 생산용 원료 (1) Raw materials for essential oil production
본 발명의 셀룰라이트 저감용 천연 혼합 에센셜 오일 제조를 위해 전남에서 재배하는 자원은 품명이 분명한 농산자원을 농가와 계약재배하여 구하였으며 국내산 건조 참당귀는 한약재상에서 구입하였고 생물 토생강은 전북에서 재배하여 유통되는 것을 구입하였으며 유자를 제외한 오렌지, 레몬은 켈리포니아산으로 해외에서 직수입되어 농산물도매상에서 판매하는 신선한 과일을 대량 구매하여 시료로 사용하였다. For the production of natural mixed essential oil for cellulite reduction of the present invention, resources cultivated in Jeonnam were obtained by contract cultivation with farms of agricultural resources with clear names, domestic dried donkeys were purchased from oriental medicine vendors, and biogenic ginger was cultivated in Jeonbuk. Oranges and lemons, excluding citrons, were imported from California, and fresh fruits sold at agricultural wholesalers were purchased in large quantities and used as samples.
에센셜 오일 추출방법에서 한약재를 제외한 모든 시료는 제철에 구입하여 곧바로 추출하였으며 곧바로 추출이 어려운 시료는 냉동저장하여 되도록 제철에 추출하는 것을 원칙으로 하였다. In the essential oil extraction method, all samples except herbal medicines were purchased in season and extracted immediately, and samples that were difficult to extract immediately were frozen and stored and extracted in season as much as possible.
(2) 에센셜 오일 생산방법 (2) Essential oil production method
에센셜 오일 대량생산장치인 물-수증기증류장치는 본 발명자가 개발하여 특허등록된 장치로 50kg(내용적) 증류부와 냉각응축기, 감압용 진공펌프 등으로 구성하였다. The water-steam distillation device, which is an essential oil mass production device, is a device developed and patented by the present inventor, and is composed of a 50 kg (inner volume) distillation unit, a cooling condenser, and a vacuum pump for pressure reduction.
물-수증기증류추출기법을 이용한 에센셜 오일 생산시 증류추출기의 내솥에 추출하고자 하는 일정양의 시료를 넣고 추출용 용매인 증류수를 일정비율로 넣어 하이드로졸(hydrosol, 즉 일명 방향수) 생산 속도가 일정하도록 가열온도를 조절하여 에센셜 오일과 하이드로졸을 동시에 추출하였다. When producing essential oils using the water-steam distillation extraction method, a certain amount of sample to be extracted is placed in the inner pot of the distillation extractor, and distilled water, the solvent for extraction, is added in a certain ratio so that the production rate of hydrosol (aka aromatic water) is constant. Essential oil and hydrosol were simultaneously extracted by adjusting the heating temperature so that
증류추출에 의한 에센셜 오일생산 종료시간은 냉각관에서 흐르는 하이드로졸에서 정유물질이 보이지 않을 때까지 추출하여 종료된 시점까지를 총정유 추출시간으로 하여 에센셜 오일 생산량 및 수율을 조사하였다.The essential oil production and yield were investigated by taking the essential oil extraction time until the essential oil was not visible in the hydrosol flowing through the cooling tube and taking the total essential oil extraction time until the end.
(생물)sample name
(Biology)
(재배지)main producing area
(plantation)
(월)harvest
(month)
부위extraction
part
(%, D.W.)Moisture content
(%, DW)
투입량Raw material
input
(생물)sample name
(Biology)
투입량
(L)water
input
(L)
추출시간
(hrs/10kg)total distillation
extraction time
(hrs/10kg)
생산량
(ml/10kg)total oil
output
(ml/10kg)
생 산 량
(㎖/kg)unit essential oil
output
(mL/kg)
수율
(%, F.W.)essential oil
transference number
(%, FW)
2. 천연 에센셜 오일의 향강도 검사 2. Inspection of aroma strength of natural essential oils
향강도는 향강도 측정기(e-nose(OMU-SN), Futaba, Japan)를 이용하여 증류추출전 원료와 에센셜 오일의 향강도와 향질을 측정하였으며 측정방법은 공기(무취)를 대조구로 하여 측정하고자 하는 시료를 냄새봉투(Sampling bag, 3liter)에 넣어 측정하는데 시료는 1g, 에센셜 오일은 1㎕를 붕투에 투입하여 측정하였다. 향강도 측정기기는 각종 취기, 향기 등의 환원성 가스 측정을 위한 초고감도 반도체 듀얼센서를 가진 e-nose(일본)이며 향강도 표시는 기기상 나타낸 수치를 무취인 공기를 대조구로 하여 상대 값을 임의의 단위인 A.I.로 표시하였다.Fragrance strength was measured by using a fragrance strength measuring instrument (e-nose (OMU-SN), Futaba, Japan) before distillation extraction to measure the fragrance strength and quality of essential oils, and the measurement method was measured using air (odorless) as a control. The sample to be measured was put into a sampling bag (3 liter) and measured by putting 1 g of the sample and 1 μl of the essential oil into the bag. The fragrance intensity measuring device is an e-nose (Japan) with an ultra-sensitive semiconductor dual sensor for measuring reducing gases such as various odors and fragrances. It is expressed as A.I., the unit of
(오일/원료)fragrance intensity index
(oil/raw material)
3. 에센셜 오일의 주요 휘발성 유용성분 분석 및 향기특성 3. Analysis of major volatile useful components and fragrance characteristics of essential oils
상기 실시 예 2에서 추출된 에센셜 오일별로 함유된 휘발성 유기화합물의 성분을 아래 표와 같은 조건에서 가스 크로마토그래피-질량 분석기(gas chromatography-mass spectrometry, GC-MS)로 분석하였다.Components of volatile organic compounds contained in each essential oil extracted in Example 2 were analyzed by gas chromatography-mass spectrometry (GC-MS) under the conditions shown in the table below.
천연향료 대량생산 공정품질표준화를 통해 생산된 에센셜 오일을 GC-MASS 분석을 통해 향기성분 라이브러리 탐색 및 각 향기성분에 대한 함량은 에센셜 오일 전체 향기성분에 대한 각 성분의 면적비(area%)로 하였다. 각 자원별 주성분은 에센셜 오일은 1.5~2% 이상인 성분을 주성분으로 하였다.Essential oils produced through quality standardization of natural fragrance mass production process were searched for a library of fragrance components through GC-MASS analysis, and the content of each fragrance component was the area ratio (area%) of each component to the total fragrance component of essential oil. The main component of each resource was essential oil with 1.5~2% or more as the main component.
4. 향심리유형 검사에 의한 에센셜 오일의 아로마테라피 효과 검증 4. Verification of aromatherapy effect of essential oils by psychopsychotype test
1) 에센셜 오일별 뇌파분석(EEG Analysis)에 의한 향심리 유형검사 방법 1) Psychological type test method by EEG analysis for each essential oil
(1) 건식 뇌파 측정시스템 (1) Dry EEG measurement system
유무선 DryEEG(건식뇌파) 시스템을 이용한 뇌파측정기로 EEG, ECG, EMG 채널을 동시에 측정 가능한 장비로 평상시의 중추 및 자율신경계와 각 향을 맡았을 때를 비교하여 피험자에게 각성 혹은 진정(이완)효과가 통계적으로 유의한지를 확인함. It is an EEG measuring device using a wired and wireless DryEEG (dry brain wave) system that can measure EEG, ECG, and EMG channels at the same time. It compares the normal central and autonomic nervous system and when each scent is used to awaken or calm (relax) the subject. Check whether it is statistically significant.
(2) 연구수행 절차 및 방법은 아래 그림과 같이 실시하였다.(2) The research procedure and method were carried out as shown in the figure below.
(3) 향심리 측정 실험진행 방법 (3) How to conduct a psychopsychological experiment
실험장비는 건식뇌파 측정장치인 DSI-24((주)지앤에스인터내셔널)이며 실험장소는 전남농업기술원 향료실험실에서 실시하였으며 측정대상은 연령대별로 남, 녀 8명씩 뇌파와 심전도를 동시에 측정하였다. The experimental equipment is DSI-24 (GNS International Co., Ltd.), a dry brain wave measuring device, and the experiment place was conducted in the fragrance laboratory of the Jeonnam Agricultural Research and Extension Services.
(4) 측정 내용 (4) Measurement contents
뇌파측정은 EEG, ECG, EMG를 심전도 RRV(R-R Variability, HRV)분석을 통해 혈액순환 펌프작용을 하는 심장의 전기적 활동이 반영된 신호를 이용하여 연속된 R피크들간의 시간 간격(R-R Interval)인 심박간격의 변화를 측정하여 RR간격의 미세한 변화패턴에 따른 스트레스에 민감하게 반응하는 자율신경(교감과 부교감신경계)의 활동 양상을 평가하여 스트레스 정도를 측정하였다. EEG, ECG, and EMG are measured through electrocardiogram RRV (R-R Variability, HRV) analysis, and the heart rate, which is the time interval between consecutive R-peaks, is measured by using signals reflecting the electrical activity of the heart that pumps blood circulation. The degree of stress was measured by evaluating the activity of the autonomic nervous system (sympathetic and parasympathetic nervous system), which responds sensitively to stress according to the minute change pattern of the RR interval by measuring the change in the interval.
교감신경계는 공격, 방어적인 스트레스 상황에서 주로 활성도가 높아지며 심박동수 증가, 혈압 및 혈당 증가, 자발근육으로의 혈류량증가, 땀분비, 내부장기로의 혈유감소 등을 유발하며, 부교감신경계는 편안한 신체 이완상태에서 부교감신경 활성도가 증가되어 심박동수 및 혈압감소, 침분비 증가, 장운동의 증가, 잠이 오도록 유발한다. The sympathetic nervous system is mainly active in aggressive and defensive stress situations, and causes an increase in heart rate, an increase in blood pressure and blood sugar, an increase in blood flow to voluntary muscles, secretion of sweat, and a decrease in blood flow to internal organs. The parasympathetic nervous system causes comfortable body relaxation. In this state, parasympathetic nerve activity is increased, leading to decreased heart rate and blood pressure, increased salivary secretion, increased intestinal motility, and sleep.
(5) 후각에 의한 실험진행 순서는 아래 그림과 같다.(5) The sequence of experiments by the sense of smell is shown in the figure below.
(6) 감성반응 통계처리 방법 (6) Emotional response statistical processing method
뇌파 반응에 대한 통계 분석과 감성반응은 Statistical Package for the Social Sciences (SPSS) ver.(IBM, USA)을 사용하여 반복측정 분산분석(repeated measure analysis of variance)을 실시하였고, 95% 신뢰수준에서 Tukey's test를 통해 사후검증을 하였다.For statistical analysis of EEG responses and emotional responses, repeated measure analysis of variance was performed using the Statistical Package for the Social Sciences (SPSS) ver. (IBM, USA), and at the 95% confidence level, Tukey's The post-hoc test was performed.
(7) 향심리 측정위한 놔파분석 및 지표 설명(7) Brain wave analysis and index description for measuring psychopsychometry
가. 파분석지표go. wave analysis index
나. 뇌파분석지표 설명me. EEG analysis index explanation
다. 심전도(HRV) 분석지표와 지표 설명all. Electrocardiogram (HRV) analysis index and indicator description
2) 에센셜 오일별 뇌파분석(EEG Analysis)에 의한 향심리 유형 평가 2) Evaluation of psychosomatic types by EEG analysis for each essential oil
(1) 에센셜 오일별 뇌파분석(EEG Analysis)에 의한 주의 집중력(RSMR) 평가 (1) Evaluation of attention concentration (RSMR) by essential oil-specific EEG analysis
에센셜 오일에 대한 향심리유형 평가에서 13-15 Hz 대역의 뇌파로 각성시 활성되는 상대감각운동리듬(relative sensorimotor rhythm, RSMR)을 측정하였다. 즉 과잉행동이나 충동성 등의 행동이 적을 때 활발하게 출현하는 RSMR은 뇌를 자극하여 안정감과 편안함을 느껴 보다 높은 집중력을 향상시키는 효과를 주의집중력(RSMR)이라고 말하며 천연 에센셜 오일별 주의집중력 효과를 조사하였다. The relative sensorimotor rhythm (RSMR), which is activated upon awakening, was measured with EEG in the 13-15 Hz band in the evaluation of the psychotropic type for essential oils. In other words, RSMR, which appears actively when behaviors such as hyperactivity or impulsivity are low, stimulates the brain to feel a sense of stability and comfort, and the effect of improving higher concentration is called RSMR. investigated.
주의집중력(RSMR)의 값은 무향으로 측정한 무처리구의 값에서 에센셜 오일로 측정한 값을 뺀 것으로 (-) 값이면 에센셜 오일의 값이 무처리구 값보다 큰 것으로 (-)값이 커질수록 에센셜 오일의 주의집중력(RSMR) 효과가 증가하며, 반대로 주의집중력(RSMR)의 값이 (+) 값으로 커질수록 무향측정인 무처리구가 에센셜 오일보다 효과가 더 크며 증가하는 것을 의한다. The value of attention concentration (RSMR) is obtained by subtracting the value measured with essential oil from the value measured with no fragrance. If the value is (-), the value of essential oil is greater than that of the untreated group. The effect of attention concentration (RSMR) increases, and conversely, as the value of attention concentration (RSMR) increases to a (+) value, the effect of the untreated group, which is an aromatization measure, is greater than that of essential oil.
주의 집중력이 우수한 에센셜 오일의 순서는 스윗오렌지> 생강, 로즈마리> 레몬> 편백엽> 유자> 박하> 참당귀 순이었으며 로즈제라늄은 효과가 없는 것으로 나타났다. 그리고 0.05 이하의 고도의 유인성을 보여 주의 집중력 효과가 우수한 에센셜 오일은 스윗오렌지, 로즈마리, 생강, 레몬 등이었다.The order of essential oils with excellent attention concentration was sweet orange > ginger, rosemary > lemon > cypress > citron > peppermint > donkey, and rose geranium was found to be ineffective. In addition, essential oils showing a high level of attraction of less than 0.05 and having excellent attention concentration effects were sweet orange, rosemary, ginger, and lemon.
오일essential
oil
(2) 에센셜 오일별 뇌파분석(EEG Analysis)에 의한 각성(RG) 평가(2) Evaluation of arousal (RG) by EEG analysis for each essential oil
에센셜 오일별 뇌파분석(EEG Analysis)에서 집중시 출현하는 상대 감마파(Relative gamma power, RG; 30-50 Hz)를 측정하였으며, Gamma파의 상대파워인 RG는 복잡한 문제해결, 집중시 출현하는 RG의 값으로 긴장, 각성 또는 고도의 집중을 나타내는 뇌파로 향심리 유형평가에서 각성이라고 하며 그 반대는 진정을 나타내는 중요한 뇌파이다. RG값이 (+) 값이면 무향측정인 무처리구가 에센셜 오일의 값보다 더 큰 것으로 무향측정이 긴장, 각성 또는 고도의 집중을 나타내는 반면 에센셜 오일은 그 반대로 무처리구의 값보다 감소하여 그 반대성향인 긴장완화, 이완효과(Relaxing)를 가지는 "진정작용"을 나타내며, RG값이 (-) 값을 나타내면 대조구인 무향측정값보다 에센셜 오일의 측정값이 더 큰 것으로 에센셜 오일이 긴장, 고도집중효과로 각성작용을 나타낸다. Relative gamma power (RG; 30-50 Hz) that appears during concentration was measured in EEG Analysis for each essential oil. It is an EEG that indicates tension, arousal, or high concentration with a value of . It is called arousal in the evaluation of psychopsychic type, and the opposite is an important EEG that indicates calm. If the RG value is a (+) value, the value of the untreated group, which is an aroma measurement, is higher than that of the essential oil, indicating tension, arousal, or high concentration, whereas the value of the essential oil, on the contrary, is lower than the value of the untreated group, which is the opposite tendency, tension. It represents "sedation" with a relaxation and relaxation effect, and if the RG value shows a (-) value, the measured value of essential oil is greater than the non-scented value of the control group, and the essential oil awakens with tension and concentration. indicates action.
오일essential
oil
본 연구의 에센셜 오일별 뇌파분석에 의한 RG값이 (+) 값을 나타내어 진정작용으로 긴장완화, 이완효과(Relaxing)를 나타내며 진정작용이 높은 순서는 박하> 로즈제라늄> 편백엽> 유자> 로즈마리> 레몬> 참당귀 순이었으며 0.05이하의 유의성을 보여 진정효과가 우수한 에센셜 오일은 박하와 로즈제라늄이었다. RG값이 (-) 값을 나타내어 각성작용을 나타내며 각성효과가 높은 에센셜 오일 순서는 스윗오렌지> 생강 순으로 모두 0.05이하의 유의성을 보여 각성효과가 우수하며 긴장과 고도의 집중력 효과가 있다. The RG value by the EEG analysis of each essential oil in this study shows a (+) value, indicating a relaxation effect (relaxing) by sedation. Lemon > Angelica quinoa, and the essential oils with excellent sedative effects with a significance of less than 0.05 were peppermint and rose geranium. The RG value shows a (-) value, indicating an arousal effect, and the order of essential oils with a high arousal effect is sweet orange > ginger, all with a significance of less than 0.05, so the arousal effect is excellent, and there is a tension and high concentration effect.
에센셜 오일별 향심리유형 평가에서 박하, 로즈제라늄, 편백엽, 유자, 로즈마리, 레몬, 참당귀 등은 진정작용, 스윗오렌지, 생강 등은 각성작용으로 분류되었다. In the evaluation of psychosomatic type by essential oil, peppermint, rose geranium, cypress leaf, citron, rosemary, lemon, and angelica were classified as sedative, while sweet orange and ginger were classified as awakening.
(3) 아로마테라피 에센셜 오일별 심전도(HRV) 검사에 의한 항스트레스성 감성 평가 (3) Evaluation of anti-stress sensitivity by electrocardiogram (HRV) test for each aromatherapy essential oil
아로마테라피 에센셜 오일별 무향을 대조구로 하여 교감신경(NormLF)과 부교감신경(NormHF)에 의한 진정과 각성효과를 조사한 결과에 따른 항스트레스성 감성 평가는 아래 표와 같다. The table below shows the anti-stress emotional evaluation according to the results of investigating the sedation and awakening effects by the sympathetic nerve (NormLF) and parasympathetic nerve (NormHF) with unscented control for each aromatherapy essential oil.
에센셜 오일별 교감신경(NormLF)과 부교감신경(NormHF)에 의한 항스트레스성 검사에서 무향측정을 무처리구로 하여 교감신경(NormLF)의 경우 무처리구 값에서 에센셜 오일의 값을 뺀 값이 (+) 값이 되면 에센셜 오일은 무처리구보다 교감신경이 감소하여 부교감신경 값이 증가하게 된다. 이때 부교감신경의 무처리구 값에서 증가한 에센셜 오일의 부교감신경 값을 빼면 (-) 값이 되어 에센셜 오일은 진정효과를 가지며 심리적 이완효과가 증가하여 스트레스가 감소한다. 이와는 반대로 교감신경에서 무처리 값이 에센셜 오일의 값보다 작아 (-) 값이 되면 에센셜 오일의 교감신경 값은 증가하게 되고 부교감신경 값은 감소하여 무처리구 값에서 뺀 에센셜 오일의 부교감신경 값은 (+) 값이 되어 각성효과가 되고 심리적 긴장이 증가되어 스트레스 완화효과는 없으나 활력은 증가된다. In the antistress test by the sympathetic nerve (NormLF) and the parasympathetic nerve (NormHF) by essential oil, the value obtained by subtracting the value of the essential oil from the value of the untreated group in the case of the sympathetic nerve (NormLF) is a (+) value. In case of essential oil, the parasympathetic nerve value increases as the sympathetic nerve decreases compared to the untreated group. At this time, subtracting the parasympathetic value of the increased essential oil from the value of the untreated parasympathetic nerve results in a value of (-), and the essential oil has a calming effect and reduces stress by increasing the psychological relaxation effect. Conversely, if the untreated value in the sympathetic nerve is smaller than the value of the essential oil and becomes a (-) value, the sympathetic nerve value of the essential oil increases and the parasympathetic nerve value decreases, so the parasympathetic nerve value of the essential oil subtracted from the untreated value is (+) ), it becomes an arousal effect and increases psychological tension, so there is no stress relieving effect, but vitality is increased.
무처리(무향측정) 대비 부교감신경(NormHF) 값이 증가하여 (-) 값을 나타내는 에센셜 오일은 참당귀, 유자, 박하, 편백엽, 로즈마리, 로즈제라늄, 레몬 등으로 이완, 진정효과를 나타내었다. 무처리(무향측정) 대비 교감신경(NormLF)이 증가하여 (+)값을 나타내는 에센셜 오일은 생강, 스윗오렌지였으며 긴장, 각성효과를 나타내었다. 따라서 마음의 안정감과 진정효과를 주어 스트레스 완화 효과가 큰 에센셜 오일 순서는 레몬> 참당귀> 로즈마리> 유자> 박하> 로즈제라늄> 편백엽 순이었으며 레몬, 참당귀, 로즈마리는 0.05% 이하의 유의성을 보여 스트레스 완화효과가 우수한 것으로 나타났다. 그리고 긴장감과 각성효과가 있어 활력을 주는 효과가 큰 에센셜 오일은 생강> 스윗오렌지이며 특히 생강은 0.01% 이하의 강한 각성작용을 보여 활력을 주는 효과가 매우 우수하였다. Compared to untreated (no fragrance measurement), the parasympathetic nerve (NormHF) value increased, and the essential oils showing a (-) value were angelica, citron, peppermint, cypress, rosemary, rose geranium, and lemon, which showed a relaxing and soothing effect. . Compared to untreated (no scent measurement), the sympathetic nerve (NormLF) increased and the essential oils showing (+) values were ginger and sweet orange, which showed tension and awakening effects. Therefore, the order of essential oils with the greatest stress relieving effect by providing a sense of calm and calming effect was lemon > donkey > rosemary > citron > peppermint > rose geranium > cypress, and lemon, donkey, and rosemary showed a significance of less than 0.05%. It has been shown to have an excellent stress relieving effect. In addition, the essential oil that has a great energizing effect because of its tension and awakening effect is ginger>sweet orange.
제라늄 rose
geranium
오렌지sweet
orange
(4) 천연에센셜 오일별 형심리 효능 평가에 의한 아로마테라피 종합 평가(4) Comprehensive evaluation of aromatherapy by psychological efficacy evaluation of each natural essential oil
에센셜 오일별 형심리 효능 평가에 의한 아로마테라피 효과를 종합 평가한 결과 진정, 이완(Relaxing) 효과, 불안해소, 스트레스완화, 심리적 안정감을 주는 에센셜 오일은 참당귀, 유자, 박하, 편백엽, 로즈마리, 로즈제라늄, 레몬 등이었다. As a result of the comprehensive evaluation of aromatherapy effects by psychological efficacy evaluation of each essential oil, essential oils that provide calming, relaxing effects, anxiety relief, stress relief, and psychological stability are angelica, citron, peppermint, cypress, rosemary, Rose geranium, lemon, etc.
각성, 고도집중력 향상, 항우울, 활력증진, 정신고양, 긍정효과를 가지는 에센셜 오일은 생강, 스윗오렌지 등이었다.Essential oils with arousal, high concentration enhancement, antidepressant, vitality enhancement, mental enhancement, and positive effects were ginger and sweet orange.
오일essential
oil
(RSMR)concentration
(RSMR)
(RG) sedation or awakening
(RG)
스트레스 완화 우수 Relaxation, fatigue recovery.
Excellent for stress relief
스트레스 완화 높음 Relaxation, fatigue recovery.
high stress relief
활력증가 우수tension, focus,
Excellent vitality increase
스트레스 완화Relaxation, fatigue recovery.
stress relief
활력증가 높음tension, focus,
high vitality
스트레스 완화 우수 Relaxation, fatigue recovery.
Excellent for stress relief
5. 아로마테라피 효과가 있는 셀룰라이트 저감 5. Cellulite reduction with aromatherapy effect 향장료 spices 조성물 개발composition development
1) 셀룰라이트 저감 아로마테라피 향장료 조성물 개발1) Development of cellulite-reducing aromatherapy cosmetic composition
차종자 등에 함유한 폴리페놀 성분 다량 함유가 체지방 감소에 도움을 주는 종일오일로 구성된 베이스 오일 A와 마음의 진정과 이완, 항우울에 효과가 있고 부교감신경을 상승시켜 피로회복 및 스트레스 완화에 도움을 주어 심리적 치유가 우수하고 셀룰라이트 저감에 도움을 주는 유용성분을 함유한 혼합 에센셜 오일 조성물 B, A+B의 혼합 조성물의 장기저장과 산화방지 및 피부 기능성 부여를 위한 천연물 유래 기능성 첨가물 C을 기본 제형으로 하여 베이스 오일 A와 아로마테라피 에센셜 오일 혼합조성물 B, 기능성 첨가물 C를 배합비율별로 처리하여 각 배합비율별로 제형된 혼합에센셜 오일 조성물의 최적 농도, 사용감 적합성, 피부안정성 등을 조사하여 최적배합 조성물을 선발한 후 최종 셀룰라이트 저감 향장료 조성물을 개발하게 되었다. 심신치유형 셀룰라이트 저감 아로마테라피 향장료 조성물 개발을 위한 각 혼합 조성물별 배합비율은 아래 표와 같다. Base oil A composed of all-day oil containing a large amount of polyphenols contained in tea seeds helps to reduce body fat, and is effective for calming and relaxing the mind and antidepressants, and helps to recover from fatigue and relieve stress by increasing the parasympathetic nerve. A mixed essential oil composition B containing useful ingredients that are excellent in psychological healing and help reduce cellulite, long-term storage of the mixed composition of A+B, and natural product-derived functional additive C for antioxidant and skin functionalization basic formulation The base oil A, the aromatherapy essential oil mixed composition B, and the functional additive C were processed according to the mixing ratio, and the optimal concentration, suitability for use, skin stability, etc. of the mixed essential oil composition formulated for each mixing ratio were investigated to determine the optimal mixing composition. After selection, the final cellulite-reducing cosmetic composition was developed. The mixing ratio of each mixed composition for the development of a cellulite-reducing aromatherapy cosmetic composition for mind and body healing is shown in the table below.
종자오일인 편백종자 오일 5 ~ 40 중량%, 동백종자 오일 5 ~ 40 중량%, 세서미종자 오일 5 ~ 40 중량%, 커피그린빈 오일 5 ~ 40 중량% 및 해바라기씨 오일 5 ~ 40 중량% 배합한 베이스 오일을 실시예 1 내지 4까지 94 중량%, 88 중량%, 81 중량%, 74 중량%씩 배합하고, 진정, 이완, 마음안정, 항우울, 피로회복 및 스트레스 완화 등 아로마터라피 효과가 있는 셀룰라이트 저감 에센셜 오일인 참당귀 5 ~ 20 중량%, 유자 5 ~ 20 중량%, 박하 5 ~ 20 중량%, 생강 5 ~ 20 중량%, 편백옆 5 ~ 20 중량%, 로즈마리 5 ~ 20 중량%, 로즈제라늄 5 ~ 20 중량%, 스윗오렌지 5 ~ 20 중량%, 레몬 5 ~ 20 중량%로 배합한 셀룰라이트 저감 아로마테라피 에센셜 오일 조성물을 실시예 1 내지 4까지 각 실시예별로 1 중량%, 7 중량%, 14 중량%, 21 중량%씩 첨가하여 시제품을 제조한 후 셀룰라이트 저감 아로마테라피 조성물에 대한 최적 배합 조건을 선발하였다.A base containing 5 to 40 wt% of seed oil, cypress seed oil, 5 to 40 wt% of camellia seed oil, 5 to 40 wt% of sesame seed oil, 5 to 40 wt% of coffee green bean oil, and 5 to 40 wt% of sunflower seed oil. 94% by weight, 88% by weight, 81% by weight, 74% by weight of the oils of Examples 1 to 4 were blended, and cellulite having aromatherapy effects such as calming, relaxation, mind stability, antidepression, fatigue recovery and stress relief Angelica 5 to 20 wt%, citron 5 to 20 wt%, mint 5 to 20 wt%, ginger 5 to 20 wt%, cypress 5 to 20 wt%, rosemary 5 to 20 wt%, rose A cellulite-reducing aromatherapy essential oil composition formulated with 5 to 20% by weight of geranium, 5 to 20% by weight of sweet orange, and 5 to 20% by weight of lemon was 1% by weight and 7% by weight for each example up to Examples 1 to 4. , 14% by weight and 21% by weight were added to prepare prototypes, and then optimal mixing conditions for the cellulite-reducing aromatherapy composition were selected.
Seed oil base ⅡA:
Seed oil base II
Aroma essential oilB:
Aroma essential oil
AdditiveC:
Additive
실시예 1 내지 4까지 배합 처리한 결과 베이스 오일과 혼합 에센셜 오일의 배합량이 높을수록 편백향과 한방향기가 증가하면서 베이스 오일에서 느껴지는 무겁고 다소 뻑뻑한 오일의 느낌이 감소하였으나 혼합 에센셜 오일의 배합량 21 중량%에서는 베이스 오일이 다소 가볍고 흡수성이 빨라 오히려 피부 마사지를 실시할 경우 전연성과 피부 보습성이 떨어지는 경향이 있었다. As a result of the blending treatment of Examples 1 to 4, the higher the blending amount of the base oil and the mixed essential oil, the more the cypress and the aromatic group, and the feeling of heavy and somewhat stiff oil felt in the base oil decreased. However, the blending amount of the mixed essential oil was 21% by weight In , the base oil was rather light and absorbed quickly, and rather, when skin massage was performed, the malleability and skin moisturizing properties tended to decrease.
셀룰라이트 저감 아로마테라피 향장료 제형처리별 피부사용감 평가는 실시예 3이 한방향과 기분 좋은 허브향기가 적정히 배합되어 기분 좋은 향취를 주어 심신이완, 진정효과가 상승되었고 마사지후 피부의 유연성, 보습성 등이 증가되어 셀룰라이트 저감 아로마테라피 향장료 조성물로서 가장 적합한 것으로 평가되어 실시예 3을 최종 심신치유형 셀룰라이트 저감 아로마테라피 향장료 조성물로 선정하였다. The cellulite-reducing aromatherapy fragrance evaluation of the skin usability by formulation treatment was carried out in Example 3, which was appropriately mixed with one-way and pleasant herbal fragrances, giving a pleasant fragrance, increasing the relaxation and soothing effect of the skin after massage, and the flexibility and moisturizing properties of the skin after massage. It was evaluated as the most suitable as a cellulite-reducing aromatherapy cosmetic composition, and the like increased, and Example 3 was selected as the final mind-body healing type cellulite-reducing aromatherapy cosmetic composition.
베이스 오일과 혼합 에센셜 오일 배합 처리별 피부사용감이 좋고 향취가 우수하며 마사지시 전연성 우수, 마사지후 보습성, 유연성 등이 우수한 배합처리는 실시예 3으로 베이스 오일(A) 81 중량%, 아로마테라피 에센셜 오일(B) 14 중량%, 기능성 첨가물(C) 5 중량%의 배합이 가장 적정한 것으로 평가되었다. 따라서 아래 추가 실험은 실시예 3의 배합 비율로 진행하였다.Base oil and mixed essential oil blending treatment has good skin feel, excellent fragrance, excellent malleability during massage, excellent moisturizing after massage, flexibility, etc. for each treatment is Example 3, 81% by weight of base oil (A), aromatherapy essential A combination of 14% by weight of oil (B) and 5% by weight of functional additive (C) was evaluated as the most appropriate. Therefore, the following additional experiments were conducted with the mixing ratio of Example 3.
(2) 셀룰라이드 저감 아로마테라피 향장료 조성물에 대한 피부 이상반응 검사(2) Skin adverse reaction test for cellulide-reducing aromatherapy cosmetic composition
셀룰라이트 저감 아로마테라피 향장료 배합비율별 처리에 대한 피부 이상반응 검사를 실시한 결과 피부 1차자극 시험 및 피부첩포검사(Skin Patch Test)에 의한 2차 알레르기 피부반응 검사 모두 피부이상반응이 나타나지 않아 선발된 피부마사지 제형에 대한 피부 안정성이 있음을 확인하였다.As a result of the skin adverse reaction test for cellulite-reducing aromatherapy fragrance treatment by mixing ratio, no adverse skin reaction was found in both the primary skin irritation test and the secondary allergic skin test by the skin patch test. It was confirmed that there is skin stability for the skin massage formulation.
항 목evaluation
item
(3) 셀룰라이트 저감 아로마테라피 향장료 조성물의 피부마사지 실시후 체지방 평가 (3) Evaluation of body fat after skin massage of cellulite-reducing aromatherapy cosmetic composition
비슷한 몸무게를 가진 사람을 대상으로 50대 남자 2명, 40여자 2명, 50대 여자 2명을 대상으로 셀룰라이트 저감 아로마테라피 향장료 조성물을 가지고 매주 1회씩 연속 4주간 1시간씩 전신 피부마사지를 실시한 후 평균 체중 감소와 기초대사량을 생체전기임피던스(Bioelectrical Impedance Analysis)를 이용하는 인바디(Inbody 770)로 조사하였다. Targeting people with a similar weight, 2 men in their 50s, 2 women in their 40s, and 2 women in their 50s received a full-body skin massage once a week for 1 hour for 4 consecutive weeks with the cellulite-reducing aromatherapy cosmetic composition. After implementation, average weight loss and basal metabolic rate were investigated with Inbody 770 using Bioelectrical Impedance Analysis.
남자는 매주 1회씩 4주간 1시간씩 전신피부마사지 체험동안 체중의 평균차이는 체험전에 비해 -0.37㎏가 감소하였고 체지방량은 -2.82㎏이 감소하였다. 그리고 골격근량 1.88㎏ 증가, 기초대사량은 75.25kcal가 증가되어 골격근량과 에너지 소모를 높이고 체중과 체지방이 조금씩 감소한 것을 확인하였다 따라서 연속 4주간 전신 피부마사지 실시를 통해 체지방과 체중이 감소하고 골격근량과 에너지 소모량이 증가한 것으로 보아 셀룰라이트 저감효과 있는 것으로 확인되었다. During the whole body skin massage experience for men once a week for 1 hour for 4 weeks, the average difference in weight decreased by -0.37kg and body fat decreased by -2.82kg compared to before the experience. In addition, skeletal muscle mass increased by 1.88 kg and basal metabolic rate increased by 75.25 kcal, which increased skeletal muscle mass and energy consumption, and it was confirmed that body weight and body fat gradually decreased. It was confirmed that there is an effect of reducing cellulite as the energy consumption increased.
복부비만이 있는 40대 여자 2명과 50대의 여자 2명의 경우 동일한 체험조건하에서 실시한 결과 체험전에 비해 체중의 평균차이는 -1.5 ~ -1.6㎏이 감소하였고 체지방량은 -1.43 ~ -2.20㎏ 감소, 골격근량은 0.41~0.93㎏ 증가, 기초대사량은 18.25 ~ 20.25kcal가 증가되어 골격근량과 에너지 소모를 높이고 체중과 체지방이 조금씩 감소한 것을 확인하였다.In the case of 2 women in their 40s and 2 women in their 50s with abdominal obesity under the same experience conditions, the average difference in body weight decreased by -1.5 to -1.6kg, body fat mass decreased by -1.43 to -2.20kg, and skeletal muscle mass compared to before the experience. It was confirmed that skeletal muscle mass and energy consumption increased, and body weight and body fat gradually decreased.
(나이)gender
(age)
BMR
(kcal)basal metabolic rate
BMR
(kcal)
(㎏)weight
(kg)
(㎏)skeletal muscle mass
(kg)
(㎏)fat mass
(kg)
(50대)other
(50s)
(A)before measurement
(A)
(B)after measurement
(B)
(40대) female
(40s)
(A)before measurement
(A)
(B)after measurement
(B)
(50대)
female
(50s)
(A)before measurement
(A)
(B)after measurement
(B)
※ 기초대사량 :(Basal Metabolic Rate, Kcal): 정상적인 신체가능을 유지하고 체내 항상성을 유지하며 자율신경계의 활동을 위해 필요한 최소한의 에너지로 주로 심장 박동, 호흡, 체온조절 등을 위한 에너지 의미※ Basal Metabolic Rate: (Basal Metabolic Rate, Kcal): This is the minimum amount of energy required for normal body function, body homeostasis, and activity of the autonomic nervous system, mainly for heartbeat, respiration, and body temperature control.
(나이)gender
(age)
(BMI)
(㎏/㎡)body mass index
(BMI)
(kg/m2)
(%)Percent Body Fat
(%)
(Waist-Hip Ratio) Abdominal fat percentage
(Waist-Hip Ratio)
(%)Obesity Degree
(%)
(53)other
(53)
(49)
female
(49)
(57)
female
(57)
남녀 차이를 비교하여 볼 때 여성보다 남성이 평균 체중감소량은 적었으나 체지방량과 기초대사량의 증가는 더 높았으며 근골격량 증가도 여성에 비해 2배 이상 증가하여 남성이 여성에 비해 효과가 더 좋은 것으로 나타났다. Comparing the differences between men and women, the average weight loss in men was less than that in women, but the increase in body fat mass and basal metabolic rate was higher, and the increase in musculoskeletal mass increased more than twice as compared to women, indicating that men had better effects than women. .
셀룰라이트 저감 아로마테라피 향장료 조성물을 이용한 전신 피부마사지 체험 횟수에 따른 비만진단에서 남자는 체질량지수, 체지방율, 복부지방율, 비만도 등 모든 항목에서 조금씩 감소를 하여 셀룰라이트 저감 아로마테라피 향장료 조성물이 약간의 비만감소 및 셀룰라이트 저감에 대한 효과가 있는 것으로 나타났다.In the diagnosis of obesity according to the number of body skin massage experiences using the cellulite-reducing aromatherapy cosmetic composition, men showed a slight decrease in all items such as body mass index, body fat percentage, abdominal fat percentage, and obesity. It has been shown to be effective in reducing obesity and cellulite.
40대와 50대 여성은 체질량지수, 체지방율, 비만도 등이 전체적으로 약간씩 감소하였으나 남성보다는 그 감소율이 적었으며 특히 복부지방율 감소는 체험전ㆍ후 변화가 -0.01로 여성이 셀룰라이트가 많이 뭉쳐있는 복부의 지방율 감소가 어렵고 쉽게 잘빠지지 않는 것을 알 수 있었다. 그리고 연령대가 40대보다 연령대가 높은 50대는 체질량지수, 체지방율, 복부지방율, 비만도의 감소가 더 적어 노화에 의한 비만 및 셀룰라이트의 감소가 더 어려운 것으로 나타났다. 그러나 남녀 모두 정도의 차이는 있었으나 체질량지수, 체지방율, 복부지방율, 비만도 등 전반적인 감소현상을 보여 전신 피부마사지 또는 여성처럼 복부를 중심으로 부분 마사지를 장기간 실시할 경우 셀룰라이트 저감 및 체지방 감소에 도움이 되는 것을 확인하였다.In women in their 40s and 50s, body mass index, body fat percentage, and obesity decreased slightly overall, but the rate of decrease was smaller than that of men. It was found that it is difficult to reduce the fat percentage of the body and does not come off easily. In addition, it was found that it was more difficult to reduce obesity and cellulite due to aging because the decrease in body mass index, body fat percentage, abdominal fat percentage, and obesity degree were smaller in those in their 50s than those in their 40s. However, although there was a difference in degree in both men and women, overall reductions in body mass index, body fat percentage, abdominal fat percentage, and obesity were shown. When a full body skin massage or a partial massage centered on the abdomen is performed for a long time, it is helpful to reduce cellulite and body fat. confirmed that it is.
(4) 셀룰라이트 저감 아로마테라피 향장료 조성물의 피부마사지 직후 피부효능 평가 (4) Evaluation of skin efficacy immediately after skin massage of cellulite-reducing aromatherapy cosmetic composition
셀룰라이트 저감 아로마테라피 향장료 조성물의 피부마사지 실시 직후 피부효능을 평가하였다. 주름이 많고 건조한 발등을 중심으로 마사지 전ㆍ후에 대한 피부효능을 평가하였다. 마사지 받기전 피부상태(A)와 아로마테라피 전신마사지후 피부상태(B)를 모발이나 특정 피부 부위를 자세히 볼 수 있는 독특한 USB 스킨 카메라가 부착된 피부분석기(Visioscope PC 35, 호주 메디샤)로 조사하여 체험 전ㆍ후에 대한 피부효능 차이(B-A)를 조사하였다.Skin efficacy of the cellulite-reducing aromatherapy cosmetic composition was evaluated immediately after skin massage. The skin efficacy before and after massage was evaluated, focusing on dry insteps with many wrinkles. Skin condition before massage (A) and skin condition after aromatherapy full body massage (B) were investigated with a skin analyzer (Visioscope PC 35, Australia Medisha) equipped with a unique USB skin camera that allows you to see hair or specific skin areas in detail. The difference in skin efficacy (B-A) before and after the experience was investigated.
발등피부는 피부마사지 체험전에 비해 체험후 유분감과 수분량은 증가하고 각질, 모공, 색소침착, 주름 등은 모두가 감소를 하였다. 이러한 결과를 통해 마사지 체험전 발등은 피부가 연하고 부드러운 반면 햇빛을 많이 받아 피부가 건조하며 색소침착과 주름 및 각질이 많은 것을 피부효능 검사를 통해 알 수 있었다. 그리고 1시간동안 피부마사지후 피부의 유분감과 수분량이 증가하였고 각질, 모공, 색소침착, 주름 등은 체험전에 비해 모두 감소를 하여 각질제거, 모공수축, 미백, 주름감소의 효과가 좋으며 피부의 탄력과 보습이 증가하여 셀룰라이트 저감 아로마테라피 향장료를 이용한 림프드레나쥐 전신 마사지가 전반적인 피부효능을 증가시키는 것을 알 수 있었다. 그리고 이들 피부 효능중 특히 각질의 제거가 가장 많이 감소하여 피부마사지에 의한 각질 제거효과가 우수한 것으로 나타났다. In the instep skin, compared to before the skin massage experience, the amount of oil and moisture increased after the experience, and dead skin cells, pores, pigmentation, and wrinkles all decreased. Through these results, it was found through the skin efficacy test that the instep of the feet before the massage experience had soft and soft skin, but the skin was dry due to a lot of sunlight, and there were many pigmentation, wrinkles, and dead skin cells. In addition, after 1 hour of skin massage, the amount of oil and moisture of the skin increased, and dead skin cells, pores, pigmentation, and wrinkles all decreased compared to before the experience. Reducing cellulite by increasing moisturization It was found that lymphatic drain body massage using aromatherapy spices increased overall skin efficacy. In addition, among these skin effects, the removal of dead skin cells was reduced the most, so the effect of removing dead skin cells by skin massage was excellent.
전신사지후
(B)aromatherapy
After whole body limb
(B)
Claims (9)
An aromatherapy composition for psychological stabilization and cellulite reduction comprising essential oils including donkey oil, citron oil, peppermint oil, ginger oil, cypress oil, rosemary oil, rose geranium oil, sweet orange oil, and lemon oil.
상기 에센셜 오일은 참당귀 오일 5 ~ 20 중량%, 유자 오일 5 ~ 20 중량%, 박하 오일 5 ~ 20 중량%, 생강 오일 5 ~ 20 중량%, 편백엽 오일 5 ~ 20 중량%, 로즈마리 오일 5 ~ 20 중량%, 로즈제랴늄 오일 5 ~ 20 중량%, 스윗오렌지 오일 5 ~ 20 중량%, 레몬 오일 5 ~ 20 중량% 포함하는 것을 특징으로 하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물.
According to claim 1,
The essential oils include 5 to 20% by weight of angelica oil, 5 to 20% by weight of citron oil, 5 to 20% by weight of peppermint oil, 5 to 20% by weight of ginger oil, 5 to 20% by weight of cypress oil, and 5 to 20% by weight of rosemary oil. 20% by weight, 5 to 20% by weight of rose geranium oil, 5 to 20% by weight of sweet orange oil, 5 to 20% by weight of lemon oil An aromatherapy composition for psychological stability and cellulite reduction.
편백종자 오일, 동백종자 오일, 세서미종자 오일, 커피그린빈 오일 및 해바라기씨 오일을 포함하는 베이스 오일 및
Vitamin E, 스쿠알란(Squalane), 이데베논(Idebenone), 유자씨추출액을 포함하는 기능성 첨가제를 더 포함하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물.
According to claim 1,
Base oils including cypress seed oil, camellia seed oil, sesame seed oil, coffee green bean oil and sunflower seed oil, and
An aromatherapy composition for psychological stability and cellulite reduction further comprising functional additives including Vitamin E, squalane, idebenone, and citron seed extract.
베이스 오일 74 ~ 98 중량%, 에센셜 오일 1 ~ 21 중량% 및 기능성 첨가물 1 ~ 5중량%를 포함하는 것을 특징으로 하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물.
According to claim 3,
An aromatherapy composition for psychological stability and cellulite reduction, comprising 74 to 98% by weight of a base oil, 1 to 21% by weight of an essential oil, and 1 to 5% by weight of a functional additive.
상기 베이스 오일은 편백종자 오일 5 ~ 40 중량%, 동백종자 오일 5 ~ 40 중량%, 세서미종자 오일 5 ~ 40 중량%, 커피그린빈 오일 5 ~ 40 중량% 및 해바라기씨 오일 5 ~ 40 중량% 포함하는 것을 특징으로 하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물.
According to claim 3,
The base oil includes 5 to 40% by weight of cypress seed oil, 5 to 40% by weight of camellia seed oil, 5 to 40% by weight of sesame seed oil, 5 to 40% by weight of coffee green bean oil, and 5 to 40% by weight of sunflower seed oil. Aromatherapy composition for psychological stability and cellulite reduction, characterized in that.
상기 기능성 첨가제는 Vitamin E 5 ~ 40 중량%, 스쿠알란(Squalane) 5 ~ 40 중량%, 이데베논(Idebenone) 2 ~ 20 중량%, 유자씨추출액 5 ~ 40 중량% 포함하는 것을 특징으로 하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물.
According to claim 3,
The functional additive contains 5 to 40% by weight of Vitamin E, 5 to 40% by weight of Squalane, 2 to 20% by weight of Idebenone, and 5 to 40% by weight of citron seed extract. Aromatherapy composition for reducing cellulite.
상기 에센셜 오일은 RSMR(Relative Sensorimotor Rhythm) 증가, RG(Relative gamma power) 감소, 교감신경(NormLF) 감소, 부교감신경(NormHF) 증가, 진정, 이완, 마음안정, 항우울, 피로회복 및 스트레스 완화 효과를 나타내는 것을 특징으로 하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물.
According to claim 1,
The essential oil increases RSMR (Relative Sensorimotor Rhythm), RG (Relative gamma power) decreases, sympathetic nerve (NormLF) decreases, parasympathetic nerve (NormHF) increases, sedation, relaxation, mind stability, antidepressant, fatigue recovery and stress relief effects Aromatherapy composition for psychological stability and cellulite reduction, characterized in that represents.
참당귀 오일, 유자 오일, 박하 오일, 생강 오일, 편백엽 오일, 로즈마리 오일, 로즈제랴늄 오일, 스윗오렌지 오일, 레몬 오일을 혼합하여 에센셜 오일을 제조하는 단계;
Vitamin E, 스쿠알란(Squalane), 이데베논(Idebenone), 유자씨추출액을 포함하는 기능성 첨가제를 제조하는 단계;및
상기 베이스 오일, 에센셜 오일 및 기능성 첨가제를 혼합하는 단계를 포함하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물 제조방법.
Preparing a base oil by mixing cypress seed oil, camellia seed oil, sesame seed oil, coffee green bean oil and sunflower seed oil;
Preparing an essential oil by mixing angelica oil, citron oil, peppermint oil, ginger oil, cypress oil, rosemary oil, rose geranium oil, sweet orange oil, and lemon oil;
Preparing a functional additive containing Vitamin E, Squalane, Idebenone, and Citron Seed Extract; and
A method for preparing an aromatherapy composition for psychological stability and cellulite reduction comprising the step of mixing the base oil, essential oil and functional additives.
상기 베이스 오일, 에센셜 오일 및 기능성 첨가제를 혼합하는 단계는 베이스 오일 74 ~ 98 중량%, 에센셜 오일 1 ~ 21 중량% 및 기능성 첨가물 1 ~ 5중량%를 혼합하는 것을 특징으로 하는 심리 안정 및 셀룰라이트 저감용 아로마테라피 조성물 제조방법.
According to claim 8,
The step of mixing the base oil, essential oil and functional additives includes mixing 74 to 98% by weight of the base oil, 1 to 21% by weight of the essential oil and 1 to 5% by weight of the functional additive, characterized in that psychological stability and cellulite reduction A method for preparing an aromatherapy composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210169570A KR20230081492A (en) | 2021-11-30 | 2021-11-30 | Aromatherapy composition for psychological stability and cellulite reduction and manufacturingmethod thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210169570A KR20230081492A (en) | 2021-11-30 | 2021-11-30 | Aromatherapy composition for psychological stability and cellulite reduction and manufacturingmethod thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230081492A true KR20230081492A (en) | 2023-06-07 |
Family
ID=86761744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210169570A KR20230081492A (en) | 2021-11-30 | 2021-11-30 | Aromatherapy composition for psychological stability and cellulite reduction and manufacturingmethod thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230081492A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101561579B1 (en) | 2015-05-18 | 2015-10-20 | 박준학 | Hinoki Cypress, cinnamon, flaxseed oil for massage to the type of cosmetic composition as the main material and manufacturing methods |
-
2021
- 2021-11-30 KR KR1020210169570A patent/KR20230081492A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101561579B1 (en) | 2015-05-18 | 2015-10-20 | 박준학 | Hinoki Cypress, cinnamon, flaxseed oil for massage to the type of cosmetic composition as the main material and manufacturing methods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Davis | Aromatherapy An AZ: The most comprehensive guide to aromatherapy ever published | |
KR101077018B1 (en) | Cosmetic Composition with Anti-stress and Relaxing Effect | |
WO2002051428A1 (en) | Sympathetic-activating perfume composition | |
CN102755271B (en) | Compound essential oil with pressure relieving function and preparation method thereof | |
KR20120131970A (en) | Perfume composition with antistress and relexing effect, and cosmetic composition comprising the same | |
JP2011157344A (en) | Aroma composition having action for improving psychosomatic disorder and for upgrading action efficiency of brain, and preparation including the same | |
Edwards | The Aromatherapy Companion: Medicinal Uses/Ayurvedic Healing/Body-Care Blends/Perfumes & Scents/Emotional Health & Well-Being | |
KR102316168B1 (en) | Aroma oil serum composition comprising frankincense oil | |
KR101434449B1 (en) | Natural Fragrance Composition Displaying Anti-tress Using an Essential Oil Extract of Torreya nucifera Leaf | |
CN105287817B (en) | A kind of relieving mood loosens decompression, relieving mental strain and helping sleep, eliminates herbal composite tired out | |
JP2002265977A (en) | Perfume composition capable of activating sympathetic nerve | |
CN105520849B (en) | A kind of external essence oil for body passages through which vital energy circulates of releiving | |
Valnet | Essential Oils and Aromatherapy | |
KR102570019B1 (en) | A foot massage composition for aromatherapy | |
KR101715076B1 (en) | method of manufacturing and Functional shampoo a main material for A.gramineus | |
KR20230081492A (en) | Aromatherapy composition for psychological stability and cellulite reduction and manufacturingmethod thereof | |
JP2014005403A (en) | Perfume composition and cosmetics | |
Curtis et al. | Essential Oils: All-natural remedies and recipes for your mind, body and home | |
Curtis et al. | Neal's Yard Remedies Essential Oils: Restore* Rebalance* Revitalize* Feel the Benefits* Enhance Natural Beauty* Create Blends | |
JPH11343497A (en) | Cosmetic | |
KR102570858B1 (en) | A skin massage composition for aromatherapy | |
KR20040001513A (en) | Deodorizing agent composition for removing and treating bad smell from human body, and deodorizing agent produced therefrom | |
KR20010109227A (en) | Soap composition containing the Chinese herb extract and preparation there of | |
KR102244814B1 (en) | A composition for relieving stress including pelargonium graveolens oil | |
Kumar | Aroma Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |